Remi Quirion - Publications

Affiliations: 
McGill University, Montreal, QC, Canada 

386 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Zhao X, Han C, Zeng Z, Liu L, Wang H, Xu J, Feng ZP, Little PJ, Quirion R, Zheng W. Glutamate Attenuates the Survival Property of IGFR through NR2B Containing N-Methyl-D-aspartate Receptors in Cortical Neurons. Oxidative Medicine and Cellular Longevity. 2020: 5173184. PMID 32849999 DOI: 10.1155/2020/5173184  0.326
2019 Mitazaki S, Nakagawasai O, Onogi H, Watanabe K, Takahashi K, Tan-No K, Quirion R, Srivastava LK, Tadano T. Role of prefrontal cortical 5-HT receptors and serotonin transporter in the behavioral deficits in post-pubertal rats following neonatal lesion of the ventral hippocampus. Behavioural Brain Research. 112226. PMID 31521737 DOI: 10.1016/J.Bbr.2019.112226  0.378
2018 Castonguay D, Dufort-Gervais J, Ménard C, Chatterjee M, Quirion R, Bontempi B, Schneider JS, Arnsten AFT, Nairn AC, Norris CM, Ferland G, Bézard E, Gaudreau P, Lombroso PJ, Brouillette J. The Tyrosine Phosphatase STEP Is Involved in Age-Related Memory Decline. Current Biology : Cb. PMID 29576474 DOI: 10.1016/J.Cub.2018.02.047  0.704
2016 Mahar I, Albuquerque MS, Mondragon-Rodriguez S, Cavanagh C, Davoli MA, Chabot JG, Williams S, Mechawar N, Quirion R, Krantic S. Phenotypic Alterations in Hippocampal NPY- and PV-Expressing Interneurons in a Presymptomatic Transgenic Mouse Model of Alzheimer's Disease. Frontiers in Aging Neuroscience. 8: 327. PMID 28154533 DOI: 10.3389/Fnagi.2016.00327  0.784
2016 Bouvier DS, Jones EV, Quesseveur G, Davoli MA, A Ferreira T, Quirion R, Mechawar N, Murai KK. High Resolution Dissection of Reactive Glial Nets in Alzheimer's Disease. Scientific Reports. 6: 24544. PMID 27090093 DOI: 10.1038/Srep24544  0.574
2016 Morales-Medina JC, Juarez I, Dominguez-Lopez S, Kandimalla R, Gobbi G, Flores G, Quirion R. The Y2 receptor antagonist BIIE0246 reverses corticosterone-induced anxiogenic-related behavior and neuronal hypertrophy Neuropeptides. 55: 21. DOI: 10.1016/J.Npep.2015.11.058  0.768
2015 Dumont Y, Bastianetto S, Duranton A, Breton L, Quirion R. Immunohistochemical distribution of neuropeptide Y, peptide YY, pancreatic polypeptide-like immunoreactivity and their receptors in the epidermal skin of healthy women. Peptides. 70: 7-16. PMID 26002416 DOI: 10.1016/J.Peptides.2015.05.002  0.316
2015 Ménard C, Gaudreau P, Quirion R. Signaling pathways relevant to cognition-enhancing drug targets. Handbook of Experimental Pharmacology. 228: 59-98. PMID 25977080 DOI: 10.1007/978-3-319-16522-6_3  0.707
2015 Albuquerque MS, Mahar I, Davoli MA, Chabot JG, Mechawar N, Quirion R, Krantic S. Regional and sub-regional differences in hippocampal GABAergic neuronal vulnerability in the TgCRND8 mouse model of Alzheimer's disease. Frontiers in Aging Neuroscience. 7: 30. PMID 25852545 DOI: 10.3389/Fnagi.2015.00030  0.779
2015 Ménard C, Quirion R, Vigneault E, Bouchard S, Ferland G, El Mestikawy S, Gaudreau P. Glutamate presynaptic vesicular transporter and postsynaptic receptor levels correlate with spatial memory status in aging rat models. Neurobiology of Aging. 36: 1471-82. PMID 25556161 DOI: 10.1016/J.Neurobiolaging.2014.11.013  0.733
2015 Bastianetto S, Ménard C, Quirion R. Neuroprotective action of resveratrol. Biochimica Et Biophysica Acta. 1852: 1195-1201. PMID 25281824 DOI: 10.1016/J.Bbadis.2014.09.011  0.564
2014 Ménard C, Quirion R, Bouchard S, Ferland G, Gaudreau P. Glutamatergic signaling and low prodynorphin expression are associated with intact memory and reduced anxiety in rat models of healthy aging. Frontiers in Aging Neuroscience. 6: 81. PMID 24847259 DOI: 10.3389/Fnagi.2014.00081  0.7
2014 Ménard C, Herzog H, Schwarzer C, Quirion R. Possible role of dynorphins in Alzheimer's disease and age-related cognitive deficits. Neuro-Degenerative Diseases. 13: 82-5. PMID 23970097 DOI: 10.1159/000353848  0.609
2014 Menard C, Cavanagh C, Tse YC, Chabot J, Herzog H, Schwarzer C, Ferland G, Quirion R, Wong TP, Gaudreau P. O4-09-03: LOW HIPPOCAMPAL PRODYNORPHIN LEVELS ARE ASSOCIATED WITH MAINTENANCE OF MEMORY IN VARIOUS AGING RODENT MODELS Alzheimer's & Dementia. 10: P269-P269. DOI: 10.1016/J.Jalz.2014.04.435  0.684
2013 Menard C, Bastianetto S, Quirion R. Neuroprotective effects of resveratrol and epigallocatechin gallate polyphenols are mediated by the activation of protein kinase C gamma. Frontiers in Cellular Neuroscience. 7: 281. PMID 24421757 DOI: 10.3389/Fncel.2013.00281  0.624
2013 Jiang J, Wang D, Zhou X, Huo Y, Chen T, Hu F, Quirion R, Hong Y. Effect of Mas-related gene (Mrg) receptors on hyperalgesia in rats with CFA-induced inflammation via direct and indirect mechanisms. British Journal of Pharmacology. 170: 1027-40. PMID 23909597 DOI: 10.1111/Bph.12326  0.386
2013 Ménard C, Tse YC, Cavanagh C, Chabot JG, Herzog H, Schwarzer C, Wong TP, Quirion R. Knockdown of prodynorphin gene prevents cognitive decline, reduces anxiety, and rescues loss of group 1 metabotropic glutamate receptor function in aging. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 12792-804. PMID 23904614 DOI: 10.1523/Jneurosci.0290-13.2013  0.634
2013 Goutagny R, Gu N, Cavanagh C, Jackson J, Chabot JG, Quirion R, Krantic S, Williams S. Alterations in hippocampal network oscillations and theta-gamma coupling arise before Aβ overproduction in a mouse model of Alzheimer's disease. The European Journal of Neuroscience. 37: 1896-902. PMID 23773058 DOI: 10.1111/Ejn.12233  0.3
2013 Farso M, Ménard C, Colby-Milley J, Quirion R. Immune marker CD68 correlates with cognitive impairment in normally aged rats. Neurobiology of Aging. 34: 1971-6. PMID 23523271 DOI: 10.1016/J.Neurobiolaging.2013.02.008  0.611
2013 Veyrat-Durebex C, Quirion R, Ferland G, Dumont Y, Gaudreau P. Aging and long-term caloric restriction regulate neuropeptide Y receptor subtype densities in the rat brain. Neuropeptides. 47: 163-9. PMID 23410741 DOI: 10.1016/J.Npep.2013.01.001  0.629
2013 Morales-Medina JC, Juarez I, Venancio-García E, Cabrera SN, Menard C, Yu W, Flores G, Mechawar N, Quirion R. Impaired structural hippocampal plasticity is associated with emotional and memory deficits in the olfactory bulbectomized rat. Neuroscience. 236: 233-43. PMID 23357118 DOI: 10.1016/J.Neuroscience.2013.01.037  0.786
2013 Wang D, Ruan L, Hong Y, Chabot JG, Quirion R. Involvement of PKA-dependent upregulation of nNOS-CGRP in adrenomedullin-initiated mechanistic pathway underlying CFA-induced response in rats. Experimental Neurology. 239: 111-9. PMID 23063906 DOI: 10.1016/J.Expneurol.2012.10.006  0.391
2012 Morales-Medina JC, Dumont Y, Bonaventure P, Quirion R. Chronic administration of the Y2 receptor antagonist, JNJ-31020028, induced anti-depressant like-behaviors in olfactory bulbectomized rat. Neuropeptides. 46: 329-34. PMID 23103057 DOI: 10.1016/J.Npep.2012.09.009  0.381
2012 Ménard C, Quirion R. Group 1 metabotropic glutamate receptor function and its regulation of learning and memory in the aging brain. Frontiers in Pharmacology. 3: 182. PMID 23091460 DOI: 10.3389/Fphar.2012.00182  0.621
2012 Morales-Medina JC, Dominguez-Lopez S, Gobbi G, Beck-Sickinger AG, Quirion R. The selective neuropeptide Y Y5 agonist [cPP(1-7),NPY(19-23),Ala31,Aib32,Gln34]hPP differently modulates emotional processes and body weight in the rat. Behavioural Brain Research. 233: 298-304. PMID 22613731 DOI: 10.1016/J.Bbr.2012.05.015  0.337
2012 Ménard C, Quirion R. Successful cognitive aging in rats: a role for mGluR5 glutamate receptors, homer 1 proteins and downstream signaling pathways. Plos One. 7: e28666. PMID 22238580 DOI: 10.1371/Journal.Pone.0028666  0.617
2012 Krantic S, Isorce N, Mechawar N, Davoli MA, Vignault E, Albuquerque M, Chabot JG, Moyse E, Chauvin JP, Aubert I, McLaurin J, Quirion R. Hippocampal GABAergic neurons are susceptible to amyloid-β toxicity in vitro and are decreased in number in the Alzheimer's disease TgCRND8 mouse model. Journal of Alzheimer's Disease : Jad. 29: 293-308. PMID 22232004 DOI: 10.3233/Jad-2011-110830  0.698
2012 Bringas ME, Morales-Medina JC, Flores-Vivaldo Y, Negrete-Diaz JV, Aguilar-Alonso P, León-Chávez BA, Lazcano-Ortiz Z, Monroy E, Rodríguez-Moreno A, Quirion R, Flores G. Clozapine administration reverses behavioral, neuronal, and nitric oxide disturbances in the neonatal ventral hippocampus rat. Neuropharmacology. 62: 1848-57. PMID 22207157 DOI: 10.1016/J.Neuropharm.2011.12.008  0.481
2012 Morales-Medina JC, Dumont Y, Benoit CE, Bastianetto S, Flores G, Fournier A, Quirion R. Role of neuropeptide Y Y₁ and Y₂ receptors on behavioral despair in a rat model of depression with co-morbid anxiety. Neuropharmacology. 62: 200-8. PMID 21803058 DOI: 10.1016/J.Neuropharm.2011.06.030  0.554
2012 Yu W, Mechawar N, Krantic S, Chabot J, Quirion R. Upregulation of astrocytic α7 nicotinic receptors in Alzheimer's disease brain- possible relevant to amyloid pathology Molecular Neurodegeneration. 7: O7. DOI: 10.1186/1750-1326-7-S1-O7  0.581
2012 Menard C, Quirion R, Ferland G, Gaudreau P. P1-289: Anxiety state and memory abilities in rodent models of successful aging: The free-feeding Lou/C/Jall rat and calorie-restricted Sprague Dawley rat Alzheimer's & Dementia. 8: P206-P206. DOI: 10.1016/J.Jalz.2012.05.569  0.698
2011 Yu W, Mechawar N, Krantic S, Quirion R. α7 Nicotinic receptor activation reduces β-amyloid-induced apoptosis by inhibiting caspase-independent death through phosphatidylinositol 3-kinase signaling. Journal of Neurochemistry. 119: 848-58. PMID 21884524 DOI: 10.1111/J.1471-4159.2011.07466.X  0.571
2011 Benoit CE, Rowe WB, Menard C, Sarret P, Quirion R. Genomic and proteomic strategies to identify novel targets potentially involved in learning and memory. Trends in Pharmacological Sciences. 32: 43-52. PMID 21129790 DOI: 10.1016/J.Tips.2010.10.002  0.568
2011 Yu W, Gubkina O, Mechawar N, Elwell D, Quirion R, Krantic S. Expression of apoptosis-inducing factor (AIF) in the aged rat brain. Neurobiology of Aging. 32: 179-80. PMID 19251341 DOI: 10.1016/J.Neurobiolaging.2009.01.010  0.556
2011 Tillement P, Hauw J, Dubois B, Racine É, Gzil F, Duckaerts C, Amouyel P, Quirion R, Krantic S, Papadopoulos V, Belleville S, Gauthier S, Michel J, Bergman H, Poncet M. Maladie d’Alzheimer : progrès scientifiques récents et perspectives médicales Bulletin De L Academie Nationale De Medecine. 195: 1743-1747. DOI: 10.1016/S0001-4079(19)31973-9  0.355
2010 Wang Z, Ma W, Chabot JG, Quirion R. Calcitonin gene-related peptide as a regulator of neuronal CaMKII-CREB, microglial p38-NFκB and astroglial ERK-Stat1/3 cascades mediating the development of tolerance to morphine-induced analgesia. Pain. 151: 194-205. PMID 20691540 DOI: 10.1016/J.Pain.2010.07.006  0.336
2010 Yu W, Mechawar N, Krantic S, Quirion R. Evidence for the involvement of apoptosis-inducing factor-mediated caspase-independent neuronal death in Alzheimer disease. The American Journal of Pathology. 176: 2209-18. PMID 20228227 DOI: 10.2353/Ajpath.2010.090496  0.536
2010 Menard C, Quirion R. P2-298: Characterization of glutamate receptor subunits in memory-impaired and memory-unimpaired Long Evans aged rats Alzheimer's & Dementia. 6: S401-S401. DOI: 10.1016/J.Jalz.2010.05.1348  0.641
2010 Yu W, Krantic S, Mechawar N, Quirion R. P2-287: Nicotine prevents β-amyloid-induced apoptosis by inhibiting mitochondrial death pathway: A role for α7 nicotinic receptor and phosphatidylinositol 3-kinase (PI3K) Alzheimer's & Dementia. 6: S398-S398. DOI: 10.1016/J.Jalz.2010.05.1337  0.554
2009 Morales-Medina JC, Sanchez F, Flores G, Dumont Y, Quirion R. Morphological reorganization after repeated corticosterone administration in the hippocampus, nucleus accumbens and amygdala in the rat. Journal of Chemical Neuroanatomy. 38: 266-72. PMID 19505571 DOI: 10.1016/J.Jchemneu.2009.05.009  0.461
2009 Minuzzi L, Quirion R, Gauthier S, Rosa-Neto P. IC-P-140: Declines of hippocampal metabotropic glutamate receptor in Alzheimer's disease Alzheimer's & Dementia. 5: P56-P57. DOI: 10.1016/J.Jalz.2009.05.112  0.457
2008 Morales-Medina JC, Mejorada A, Romero-Curiel A, Aguilar-Alonso P, León-Chávez BA, Gamboa C, Quirion R, Flores G. Neonatal administration of N-omega-nitro-L-arginine induces permanent decrease in NO levels and hyperresponsiveness to locomotor activity by D-amphetamine in postpubertal rats. Neuropharmacology. 55: 1313-20. PMID 18790702 DOI: 10.1016/J.Neuropharm.2008.08.019  0.435
2008 Alquicer G, Morales-Medina JC, Quirion R, Flores G. Postweaning social isolation enhances morphological changes in the neonatal ventral hippocampal lesion rat model of psychosis. Journal of Chemical Neuroanatomy. 35: 179-87. PMID 18061401 DOI: 10.1016/J.Jchemneu.2007.10.001  0.451
2008 Auld DS, Mennicken F, Day JC, Quirion R. Neurotrophins differentially enhance acetylcholine release, acetylcholine content and choline acetyltransferase activity in basal forebrain neurons: Neurotrophins enhance acetylcholine release Journal of Neurochemistry. 77: 253-262. DOI: 10.1046/J.1471-4159.2001.00234.X  0.545
2007 Dumont Y, Moyse E, Fournier A, Quirion R. Distribution of peripherally injected peptide YY ([125I] PYY (3-36)) and pancreatic polypeptide ([125I] hPP) in the CNS: enrichment in the area postrema. Journal of Molecular Neuroscience : Mn. 33: 294-304. PMID 17952639 DOI: 10.1007/S12031-007-9007-9  0.347
2007 Vercauteren FG, Flores G, Ma W, Chabot JG, Geenen L, Clerens S, Fazel A, Bergeron JJ, Srivastava LK, Arckens L, Quirion R. An organelle proteomic method to study neurotransmission-related proteins, applied to a neurodevelopmental model of schizophrenia. Proteomics. 7: 3569-79. PMID 17907268 DOI: 10.1002/Pmic.200700379  0.431
2007 Mechawar N, Lacoste B, Yu WF, Srivastava LK, Quirion R. Developmental profile of neuregulin receptor ErbB4 in postnatal rat cerebral cortex and hippocampus. Neuroscience. 148: 126-39. PMID 17630218 DOI: 10.1016/J.Neuroscience.2007.04.066  0.576
2007 Krantic S, Mechawar N, Reix S, Quirion R. Apoptosis-inducing factor: a matter of neuron life and death. Progress in Neurobiology. 81: 179-96. PMID 17267093 DOI: 10.1016/J.Pneurobio.2006.12.002  0.493
2007 Reix S, Mechawar N, Susin SA, Quirion R, Krantic S. Expression of cortical and hippocampal apoptosis-inducing factor (AIF) in aging and Alzheimer's disease. Neurobiology of Aging. 28: 351-6. PMID 16504343 DOI: 10.1016/J.Neurobiolaging.2006.01.003  0.521
2006 Trang T, Ma W, Chabot JG, Quirion R, Jhamandas K. Spinal modulation of calcitonin gene-related peptide by endocannabinoids in the development of opioid physical dependence. Pain. 126: 256-71. PMID 16935424 DOI: 10.1016/J.Pain.2006.07.008  0.34
2006 Seeman P, Schwarz J, Chen JF, Szechtman H, Perreault M, McKnight GS, Roder JC, Quirion R, Boksa P, Srivastava LK, Yanai K, Weinshenker D, Sumiyoshi T. Psychosis pathways converge via D2high dopamine receptors. Synapse (New York, N.Y.). 60: 319-46. PMID 16786561 DOI: 10.1002/Syn.20303  0.38
2005 Marinelli PW, Bai L, Quirion R, Gianoulakis C. A microdialysis profile of Met-enkephalin release in the rat nucleus accumbens following alcohol administration. Alcoholism, Clinical and Experimental Research. 29: 1821-8. PMID 16269911 DOI: 10.1097/01.Alc.0000183008.62955.2E  0.302
2005 Dumont Y, Gaudreau P, Mazzuferi M, Langlois D, Chabot JG, Fournier A, Simonato M, Quirion R. BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes. British Journal of Pharmacology. 146: 1069-81. PMID 16231000 DOI: 10.1038/Sj.Bjp.0706425  0.579
2005 Krantic S, Mechawar N, Reix S, Quirion R. Molecular basis of programmed cell death involved in neurodegeneration. Trends in Neurosciences. 28: 670-6. PMID 16216345 DOI: 10.1016/J.Tins.2005.09.011  0.54
2005 Dumont Y, Moyse E, Fournier A, Quirion R. Evidence for the existence of an additional class of neuropeptide Y receptor sites in rat brain. The Journal of Pharmacology and Experimental Therapeutics. 315: 99-108. PMID 15947033 DOI: 10.1124/Jpet.105.089300  0.426
2005 Flores G, Alquicer G, Silva-Gómez AB, Zaldivar G, Stewart J, Quirion R, Srivastava LK. Alterations in dendritic morphology of prefrontal cortical and nucleus accumbens neurons in post-pubertal rats after neonatal excitotoxic lesions of the ventral hippocampus. Neuroscience. 133: 463-70. PMID 15878241 DOI: 10.1016/J.Neuroscience.2005.02.021  0.779
2005 Laplante F, Morin Y, Quirion R, Vaucher E. Acetylcholine release is elicited in the visual cortex, but not in the prefrontal cortex, by patterned visual stimulation: a dual in vivo microdialysis study with functional correlates in the rat brain. Neuroscience. 132: 501-10. PMID 15802200 DOI: 10.1016/J.Neuroscience.2004.11.059  0.301
2005 Flores G, Silva-Gómez AB, Ibáñez O, Quirion R, Srivastava LK. Comparative behavioral changes in postpubertal rats after neonatal excitotoxic lesions of the ventral hippocampus and the prefrontal cortex. Synapse (New York, N.Y.). 56: 147-53. PMID 15765522 DOI: 10.1002/Syn.20140  0.767
2005 Seeman P, Weinshenker D, Quirion R, Srivastava LK, Bhardwaj SK, Grandy DK, Premont RT, Sotnikova TD, Boksa P, El-Ghundi M, O'dowd BF, George SR, Perreault ML, Männistö PT, Robinson S, et al. Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis. Proceedings of the National Academy of Sciences of the United States of America. 102: 3513-8. PMID 15716360 DOI: 10.1073/Pnas.0409766102  0.327
2005 Laplante F, Nakagawasai O, Srivastava LK, Quirion R. Alterations in behavioral responses to a cholinergic agonist in post-pubertal rats with neonatal ventral hippocampal lesions: relationship to changes in muscarinic receptor levels. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1076-87. PMID 15637638 DOI: 10.1038/Sj.Npp.1300640  0.418
2004 Laplante F, Stevenson CW, Gratton A, Srivastava LK, Quirion R. Effects of neonatal ventral hippocampal lesion in rats on stress-induced acetylcholine release in the prefrontal cortex. Journal of Neurochemistry. 91: 1473-82. PMID 15584923 DOI: 10.1111/J.1471-4159.2004.02831.X  0.354
2004 Laplante F, Crawley JN, Quirion R. Selective reduction in ventral hippocampal acetylcholine release in awake galanin-treated rats and galanin-overexpressing transgenic mice. Regulatory Peptides. 122: 91-8. PMID 15380926 DOI: 10.1016/J.Regpep.2004.05.022  0.397
2004 Bruno MA, Clarke PB, Seltzer A, Quirion R, Burgess K, Cuello AC, Saragovi HU. Long-lasting rescue of age-associated deficits in cognition and the CNS cholinergic phenotype by a partial agonist peptidomimetic ligand of TrkA. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 8009-18. PMID 15371501 DOI: 10.1523/Jneurosci.1508-04.2004  0.375
2004 Bastianetto S, Quirion R. Natural antioxidants and neurodegenerative diseases. Frontiers in Bioscience : a Journal and Virtual Library. 9: 3447-52. PMID 15353369 DOI: 10.2741/1493  0.302
2004 Dumont Y, Thakur M, Beck-Sickinger A, Fournier A, Quirion R. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP. Neuropeptides. 38: 163-74. PMID 15337369 DOI: 10.1016/J.Npep.2004.04.007  0.415
2004 Carvajal CC, Vercauteren F, Dumont Y, Michalkiewicz M, Quirion R. Aged neuropeptide Y transgenic rats are resistant to acute stress but maintain spatial and non-spatial learning. Behavioural Brain Research. 153: 471-80. PMID 15265645 DOI: 10.1016/J.Bbr.2004.01.004  0.359
2004 Dumont Y, Chabot JG, Quirion R. Receptor autoradiography as mean to explore the possible functional relevance of neuropeptides: focus on new agonists and antagonists to study natriuretic peptides, neuropeptide Y and calcitonin gene-related peptides. Peptides. 25: 365-91. PMID 15134861 DOI: 10.1016/J.Peptides.2004.01.013  0.335
2004 Laplante F, Sibley DR, Quirion R. Reduction in acetylcholine release in the hippocampus of dopamine D5 receptor-deficient mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1620-7. PMID 15100705 DOI: 10.1038/Sj.Npp.1300467  0.34
2004 Laplante F, Srivastava LK, Quirion R. Alterations in dopaminergic modulation of prefrontal cortical acetylcholine release in post-pubertal rats with neonatal ventral hippocampal lesions. Journal of Neurochemistry. 89: 314-23. PMID 15056275 DOI: 10.1111/J.1471-4159.2004.02351.X  0.401
2004 Han YS, Zheng WH, Bastianetto S, Chabot JG, Quirion R. Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. British Journal of Pharmacology. 141: 997-1005. PMID 15028639 DOI: 10.1038/Sj.Bjp.0705688  0.309
2004 Redrobe JP, Dumont Y, Herzog H, Quirion R. Characterization of neuropeptide Y, Y(2) receptor knockout mice in two animal models of learning and memory processing. Journal of Molecular Neuroscience : Mn. 22: 159-66. PMID 14997009 DOI: 10.1385/Jmn:22:3:159  0.316
2004 Bhardwaj SK, Quirion R, Srivastava LK. Post-pubertal adrenergic changes in rats with neonatal lesions of the ventral hippocampus. Neuropharmacology. 46: 85-94. PMID 14654100 DOI: 10.1016/J.Neuropharm.2003.08.001  0.376
2004 Redrobe JP, Carvajal C, Kask A, Dumont Y, Quirion R. Neuropeptide Y and Its Receptor Subtypes in the Central Nervous System: Emphasis on Their Role in Animal Models of Psychiatric Disorders Handbook of Experimental Pharmacology. 162: 101-136. DOI: 10.1007/978-3-642-18764-3_5  0.353
2003 Bhardwaj SK, Beaudry G, Quirion R, Levesque D, Srivastava LK. Neonatal ventral hippocampus lesion leads to reductions in nerve growth factor inducible-B mRNA in the prefrontal cortex and increased amphetamine response in the nucleus accumbens and dorsal striatum. Neuroscience. 122: 669-76. PMID 14622910 DOI: 10.1016/J.Neuroscience.2003.08.016  0.349
2003 Villeneuve G, Cécyre D, Lejeune H, Drouin M, Lan R, Quirion R. Rigidified acetylcholine mimics: conformational requirements for binding to neuronal nicotinic receptors. Bioorganic & Medicinal Chemistry Letters. 13: 3847-51. PMID 14552793 DOI: 10.1016/S0960-894X(03)00728-5  0.338
2003 Rowe WB, O'Donnell JP, Pearson D, Rose GM, Meaney MJ, Quirion R. Long-term effects of BIBN-99, a selective muscarinic M2 receptor antagonist, on improving spatial memory performance in aged cognitively impaired rats. Behavioural Brain Research. 145: 171-8. PMID 14529815 DOI: 10.1016/S0166-4328(03)00116-5  0.338
2003 Danik M, Puma C, Quirion R, Williams S. Widely expressed transcripts for chemokine receptor CXCR1 in identified glutamatergic, gamma-aminobutyric acidergic, and cholinergic neurons and astrocytes of the rat brain: a single-cell reverse transcription-multiplex polymerase chain reaction study. Journal of Neuroscience Research. 74: 286-95. PMID 14515358 DOI: 10.1002/Jnr.10744  0.337
2003 Wood GK, Quirion R, Srivastava LK. Early environment contributes to developmental disruption of MPFC after neonatal ventral hippocampal lesions in rats. Synapse (New York, N.Y.). 50: 223-32. PMID 14515340 DOI: 10.1002/Syn.10265  0.341
2003 O'Donnell J, Stemmelin J, Nitta A, Brouillette J, Quirion R. Gene expression profiling following chronic NMDA receptor blockade-induced learning deficits in rats. Synapse (New York, N.Y.). 50: 171-80. PMID 14515334 DOI: 10.1002/Syn.10258  0.347
2003 Powell KJ, Quirion R, Jhamandas K. Inhibition of neurokinin-1-substance P receptor and prostanoid activity prevents and reverses the development of morphine tolerance in vivo and the morphine-induced increase in CGRP expression in cultured dorsal root ganglion neurons. The European Journal of Neuroscience. 18: 1572-83. PMID 14511336 DOI: 10.1046/J.1460-9568.2003.02887.X  0.32
2003 Juaneda C, Dumont Y, Chabot JG, Fournier A, Quirion R. Adrenomedullin receptor binding sites in rat brain and peripheral tissues. European Journal of Pharmacology. 474: 165-74. PMID 12921858 DOI: 10.1016/S0014-2999(03)02042-9  0.372
2003 Ma W, Chabot JG, Powell KJ, Jhamandas K, Dickerson IM, Quirion R. Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems. Neuroscience. 120: 677-94. PMID 12895509 DOI: 10.1016/S0306-4522(03)00159-3  0.371
2003 Dumont Y, Thakur M, Beck-Sickinger A, Fournier A, Quirion R. Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY. British Journal of Pharmacology. 139: 1360-8. PMID 12890716 DOI: 10.1038/Sj.Bjp.0705376  0.405
2003 Degroot A, Kornecook T, Quirion R, DeBow S, Parent MB. Glucose increases hippocampal extracellular acetylcholine levels upon activation of septal GABA receptors. Brain Research. 979: 71-7. PMID 12850573 DOI: 10.1016/S0006-8993(03)02868-3  0.323
2003 Pheng LH, Dumont Y, Fournier A, Chabot JG, Beaudet A, Quirion R. Agonist- and antagonist-induced sequestration/internalization of neuropeptide Y Y1 receptors in HEK293 cells. British Journal of Pharmacology. 139: 695-704. PMID 12812992 DOI: 10.1038/Sj.Bjp.0705306  0.382
2003 Redrobe JP, Dumont Y, Herzog H, Quirion R. Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice. Behavioural Brain Research. 141: 251-5. PMID 12742262 DOI: 10.1016/S0166-4328(02)00374-1  0.343
2003 Rodi D, Mazzuferi M, Bregola G, Dumont Y, Fournier A, Quirion R, Simonato M. Changes in NPY-mediated modulation of hippocampal [3H]D-aspartate outflow in the kindling model of epilepsy. Synapse (New York, N.Y.). 49: 116-24. PMID 12740867 DOI: 10.1002/Syn.10216  0.387
2003 Silva-Gómez AB, Bermudez M, Quirion R, Srivastava LK, Picazo O, Flores G. Comparative behavioral changes between male and female postpubertal rats following neonatal excitotoxic lesions of the ventral hippocampus. Brain Research. 973: 285-92. PMID 12738072 DOI: 10.1016/S0006-8993(03)02537-X  0.769
2003 Law A, Gauthier S, Quirion R. Alteration of nitric oxide synthase activity in young and aged apolipoprotein E-deficient mice. Neurobiology of Aging. 24: 187-90. PMID 12493565 DOI: 10.1016/S0197-4580(02)00068-4  0.434
2003 Sotty F, Danik M, Manseau F, Laplante F, Quirion R, Williams S. Distinct electrophysiological properties of glutamatergic, cholinergic and GABAergic rat septohippocampal neurons: novel implications for hippocampal rhythmicity The Journal of Physiology. 551: 927-943. DOI: 10.1111/J.1469-7793.2003.00927.X  0.3
2002 Auld DS, Kornecook TJ, Bastianetto S, Quirion R. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Progress in Neurobiology. 68: 209-45. PMID 12450488 DOI: 10.1016/S0301-0082(02)00079-5  0.552
2002 Seto D, Zheng WH, McNicoll A, Collier B, Quirion R, Kar S. Insulin-like growth factor-I inhibits endogenous acetylcholine release from the rat hippocampal formation: possible involvement of GABA in mediating the effects. Neuroscience. 115: 603-12. PMID 12421625 DOI: 10.1016/S0306-4522(02)00450-5  0.352
2002 Belanger S, Ma W, Chabot JG, Quirion R. Expression of calcitonin gene-related peptide, substance P and protein kinase C in cultured dorsal root ganglion neurons following chronic exposure to mu, delta and kappa opiates. Neuroscience. 115: 441-53. PMID 12421610 DOI: 10.1016/S0306-4522(02)00452-9  0.324
2002 Bastianetto S, Quirion R. Natural extracts as possible protective agents of brain aging. Neurobiology of Aging. 23: 891-97. PMID 12392793 DOI: 10.1016/S0197-4580(02)00024-6  0.307
2002 Redrobe JP, Dumont Y, Quirion R. Neuropeptide Y (NPY) and depression: from animal studies to the human condition. Life Sciences. 71: 2921-37. PMID 12384178 DOI: 10.1016/S0024-3205(02)02159-8  0.316
2002 Mollereau C, Mazarguil H, Marcus D, Quelven I, Kotani M, Lannoy V, Dumont Y, Quirion R, Detheux M, Parmentier M, Zajac JM. Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists. European Journal of Pharmacology. 451: 245-56. PMID 12242085 DOI: 10.1016/S0014-2999(02)02224-0  0.378
2002 Law A, O'Donnell J, Gauthier S, Quirion R. Neuronal and inducible nitric oxide synthase expressions and activities in the hippocampi and cortices of young adult, aged cognitively unimpaired, and impaired Long-Evans rats. Neuroscience. 112: 267-75. PMID 12044445 DOI: 10.1016/S0306-4522(02)00082-9  0.489
2002 Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, Muff R, Fischer JA, Foord SM. International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacological Reviews. 54: 233-46. PMID 12037140 DOI: 10.1124/Pr.54.2.233  0.367
2002 Kask A, Harro J, von Hörsten S, Redrobe JP, Dumont Y, Quirion R. The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neuroscience and Biobehavioral Reviews. 26: 259-83. PMID 12034130 DOI: 10.1016/S0149-7634(01)00066-5  0.41
2002 Trang T, Sutak M, Quirion R, Jhamandas K. The role of spinal neuropeptides and prostaglandins in opioid physical dependence. British Journal of Pharmacology. 136: 37-48. PMID 11976266 DOI: 10.1038/Sj.Bjp.0704681  0.301
2002 Zheng WH, Kar S, Quirion R. FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling. Journal of Neurochemistry. 80: 1049-61. PMID 11953455 DOI: 10.1046/J.0022-3042.2002.00783.X  0.308
2002 Redrobe JP, Dumont Y, Fournier A, Quirion R. The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 615-24. PMID 11927186 DOI: 10.1016/S0893-133X(01)00403-1  0.321
2002 Redrobe JP, Calo' G, Regoli D, Quirion R. Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test. Naunyn-Schmiedeberg's Archives of Pharmacology. 365: 164-7. PMID 11819035 DOI: 10.1007/S00210-001-0511-0  0.331
2002 Vaucher E, Reymond I, Najaffe R, Kar S, Quirion R, Miller MM, Franklin KB. Estrogen effects on object memory and cholinergic receptors in young and old female mice. Neurobiology of Aging. 23: 87-95. PMID 11755023 DOI: 10.1016/S0197-4580(01)00250-0  0.336
2002 Mennicken F, Chabot JG, Quirion R. Systemic administration of kainic acid in adult rat stimulates expression of the chemokine receptor CCR5 in the forebrain. Glia. 37: 124-38. PMID 11754211 DOI: 10.1002/Glia.10021  0.374
2001 Ma W, Zheng WH, Powell K, Jhamandas K, Quirion R. Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study. The European Journal of Neuroscience. 14: 1091-104. PMID 11683901 DOI: 10.1046/J.0953-816X.2001.01731.X  0.302
2001 Wood GK, Marcotte ER, Quirion R, Srivastava LK. Strain differences in the behavioural outcome of neonatal ventral hippocampal lesions are determined by the postnatal environment and not genetic factors. The European Journal of Neuroscience. 14: 1030-4. PMID 11595041 DOI: 10.1046/J.0953-816X.2001.01716.X  0.303
2001 Puma C, Danik M, Quirion R, Ramon F, Williams S. The chemokine interleukin-8 acutely reduces Ca(2+) currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs. Journal of Neurochemistry. 78: 960-71. PMID 11553670 DOI: 10.1046/J.1471-4159.2001.00469.X  0.319
2001 Law A, Gauthier S, Quirion R. Neuroprotective and neurorescuing effects of isoform-specific nitric oxide synthase inhibitors, nitric oxide scavenger, and antioxidant against beta-amyloid toxicity. British Journal of Pharmacology. 133: 1114-24. PMID 11487523 DOI: 10.1038/Sj.Bjp.0704179  0.437
2001 Juaneda C, Dumont Y, Chabot JG, Quirion R. Autoradiographic distribution of adrenomedullin receptors in the rat brain. European Journal of Pharmacology. 421: R1-2. PMID 11399270 DOI: 10.1016/S0014-2999(01)01021-4  0.396
2001 Auld DS, Mennicken F, Quirion R. Nerve growth factor rapidly induces prolonged acetylcholine release from cultured basal forebrain neurons: differentiation between neuromodulatory and neurotrophic influences. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 3375-82. PMID 11331367 DOI: 10.1523/Jneurosci.21-10-03375.2001  0.552
2001 Mollereau C, Gouardères C, Dumont Y, Kotani M, Detheux M, Doods H, Parmentier M, Quirion R, Zajac JM. Agonist and antagonist activities on human NPFF(2) receptors of the NPY ligands GR231118 and BIBP3226. British Journal of Pharmacology. 133: 1-4. PMID 11325787 DOI: 10.1038/Sj.Bjp.0704049  0.398
2001 Ma W, Zheng WH, Belanger S, Kar S, Quirion R. Effects of amyloid peptides on cell viability and expression of neuropeptides in cultured rat dorsal root ganglion neurons: a role for free radicals and protein kinase C. The European Journal of Neuroscience. 13: 1125-35. PMID 11285010 DOI: 10.1046/J.1460-9568.2001.01475.X  0.304
2001 Auld DS, Mennicken F, Day JC, Quirion R. Neurotrophins differentially enhance acetylcholine release, acetylcholine content and choline acetyltransferase activity in basal forebrain neurons. Journal of Neurochemistry. 77: 253-62. PMID 11279281 DOI: 10.1046/J.1471-4159.2001.T01-1-00234.X  0.548
2001 Law A, Gauthier S, Quirion R. Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Research. Brain Research Reviews. 35: 73-96. PMID 11245887 DOI: 10.1016/S0165-0173(00)00051-5  0.445
2001 Day JC, Kornecook TJ, Quirion R. Application of in vivo microdialysis to the study of cholinergic systems. Methods (San Diego, Calif.). 23: 21-39. PMID 11162147 DOI: 10.1006/Meth.2000.1103  0.304
2001 Law A, Doré S, Blackshaw S, Gauthier S, Quirion R. Corrigendum to “Alteration of expression levels of neuronal nitric oxide synthase and haem oxygenase-2 messenger RNA in the hippocampi and cortices of young adult and aged cognitively unimpaired and impaired Long–Evans rats” Neuroscience. 104: 281. DOI: 10.1016/S0306-4522(01)00126-9  0.341
2000 Kitaichi K, Chabot JG, Moebius FF, Flandorfer A, Glossmann H, Quirion R. Expression of the purported sigma(1) (sigma(1)) receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy. Journal of Chemical Neuroanatomy. 20: 375-87. PMID 11207432 DOI: 10.1016/S0891-0618(00)00106-X  0.422
2000 Juaneda C, Dumont Y, Quirion R. The molecular pharmacology of CGRP and related peptide receptor subtypes. Trends in Pharmacological Sciences. 21: 432-8. PMID 11121574 DOI: 10.1016/S0165-6147(00)01555-8  0.319
2000 Redrobe JP, Calo G, Guerrini R, Regoli D, Quirion R. [Nphe(1)]-Nociceptin (1-13)-NH(2), a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats. British Journal of Pharmacology. 131: 1379-84. PMID 11090110 DOI: 10.1038/Sj.Bjp.0703724  0.359
2000 Thorsell A, Michalkiewicz M, Dumont Y, Quirion R, Caberlotto L, Rimondini R, Mathé AA, Heilig M. Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proceedings of the National Academy of Sciences of the United States of America. 97: 12852-7. PMID 11058155 DOI: 10.1073/Pnas.220232997  0.316
2000 Powell KJ, Ma W, Sutak M, Doods H, Quirion R, Jhamandas K. Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists. British Journal of Pharmacology. 131: 875-84. PMID 11053206 DOI: 10.1038/Sj.Bjp.0703655  0.311
2000 Law A, Doré S, Blackshaw S, Gauthier S, Quirion R. Alteration of expression levels of neuronal nitric oxide synthase and haem oxygenase-2 messenger RNA in the hippocampi and cortices of young adult and aged cognitively unimpaired and impaired Long-Evans rats. Neuroscience. 100: 769-75. PMID 11036210 DOI: 10.1016/S0306-4522(00)00316-X  0.475
2000 Hori T, Subramaniam S, Srivastava LK, Quirion R. Behavioral and neurochemical alterations following repeated phencyclidine administration in rats with neonatal ventral hippocampal lesions. Neuropharmacology. 39: 2478-91. PMID 10974332 DOI: 10.1016/S0028-3908(00)00059-9  0.385
2000 Webster HH, Flores G, Marcotte ER, Cecyre D, Quirion R, Srivastava LK. Olfactory bulbectomy alters NMDA receptor levels in the rat prefrontal cortex. Synapse (New York, N.Y.). 37: 159-62. PMID 10881036 DOI: 10.1002/1098-2396(200008)37:2<159::Aid-Syn9>3.0.Co;2-N  0.567
2000 Coronas V, Durand M, Chabot JG, Jourdan F, Quirion R. Acetylcholine induces neuritic outgrowth in rat primary olfactory bulb cultures. Neuroscience. 98: 213-9. PMID 10854752 DOI: 10.1016/S0306-4522(00)00143-3  0.366
2000 Tong Y, Chabot JG, Shen SH, O'Dowd BF, George SR, Quirion R. Ontogenic profile of the expression of the mu opioid receptor gene in the rat telencephalon and diencephalon: an in situ hybridization study. Journal of Chemical Neuroanatomy. 18: 209-22. PMID 10781737 DOI: 10.1016/S0891-0618(00)00043-0  0.378
2000 Hersi AI, Kitaichi K, Srivastava LK, Gaudreau P, Quirion R. Dopamine D-5 receptor modulates hippocampal acetylcholine release. Brain Research. Molecular Brain Research. 76: 336-40. PMID 10762709 DOI: 10.1016/S0169-328X(00)00015-2  0.574
2000 St-Pierre JA, Nouel D, Dumont Y, Beaudet A, Quirion R. Association of neuropeptide Y Y1 receptors with glutamate-positive and NPY-positive neurons in rat hippocampal cultures. The European Journal of Neuroscience. 12: 1319-30. PMID 10762361 DOI: 10.1046/J.1460-9568.2000.00024.X  0.406
2000 Dumont Y, Cadieux A, Doods H, Pheng LH, Abounader R, Hamel E, Jacques D, Regoli D, Quirion R. BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist. British Journal of Pharmacology. 129: 1075-88. PMID 10725255 DOI: 10.1038/Sj.Bjp.0703162  0.432
2000 St-Pierre JA, Nouel D, Dumont Y, Beaudet A, Quirion R. Sub-population of cultured hippocampal astrocytes expresses neuropeptide Y Y(1) receptors. Glia. 30: 82-91. PMID 10696147 DOI: 10.1002/(Sici)1098-1136(200003)30:1<82::Aid-Glia9>3.0.Co;2-8  0.38
2000 Dumont Y, Quirion R. [(125)I]-GR231118: a high affinity radioligand to investigate neuropeptide Y Y(1) and Y(4) receptors. British Journal of Pharmacology. 129: 37-46. PMID 10694200 DOI: 10.1038/Sj.Bjp.0702983  0.426
2000 Auld DS, Day JC, Mennicken F, Quirion R. Pharmacological characterization of endogenous acetylcholine release from primary septal cultures. The Journal of Pharmacology and Experimental Therapeutics. 292: 692-7. PMID 10640307  0.484
2000 Jhamandas K, Powell K, Quirion R, Milne B. Opioid Tolerance and Physical Dependence: Role of Spinal Neuropeptides, Excitatory Amino Acids and Their Messengers Pain Research and Management. 5: 25-32. DOI: 10.1155/2000/959161  0.305
2000 Dumont Y, Cadieux A, Doods H, Fournier A, Quirion R. Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIBO3304 (Y1) and CGP71683A (Y5) Canadian Journal of Physiology and Pharmacology. 78: 116-125. DOI: 10.1139/Y99-119  0.422
1999 Redrobe JP, Dumont Y, St-Pierre JA, Quirion R. Multiple receptors for neuropeptide Y in the hippocampus: putative roles in seizures and cognition. Brain Research. 848: 153-66. PMID 10612707 DOI: 10.1016/S0006-8993(99)02119-8  0.336
1999 Kitaichi K, Day JC, Quirion R. A novel muscarinic M(4) receptor antagonist provides further evidence of an autoreceptor role for the muscarinic M(2) receptor sub-type. European Journal of Pharmacology. 383: 53-6. PMID 10556681 DOI: 10.1016/S0014-2999(99)00607-X  0.365
1999 Raposinho PD, Broqua P, Pierroz DD, Hayward A, Dumont Y, Quirion R, Junien JL, Aubert ML. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype. Endocrinology. 140: 4046-55. PMID 10465275 DOI: 10.1210/Endo.140.9.6985  0.393
1999 Pheng LH, Perron A, Quirion R, Cadieux A, Fauchère JL, Dumont Y, Regoli D. Neuropeptide Y-induced contraction is mediated by neuropeptide Y Y2 and Y4 receptors in the rat colon. European Journal of Pharmacology. 374: 85-91. PMID 10422644 DOI: 10.1016/S0014-2999(99)00296-4  0.363
1999 Flores G, Liang JJ, Sierra A, Martínez-Fong D, Quirion R, Aceves J, Srivastava LK. Expression of dopamine receptors in the subthalamic nucleus of the rat: characterization using reverse transcriptase-polymerase chain reaction and autoradiography. Neuroscience. 91: 549-56. PMID 10366012 DOI: 10.1016/S0306-4522(98)00633-2  0.689
1999 Mennicken F, Maki R, de Souza EB, Quirion R. Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends in Pharmacological Sciences. 20: 73-8. PMID 10101968 DOI: 10.1016/S0165-6147(99)01308-5  0.325
1999 Kitaichi K, Hori T, Srivastava LK, Quirion R. Antisense oligodeoxynucleotides against the muscarinic m2, but not m4, receptor supports its role as autoreceptors in the rat hippocampus. Brain Research. Molecular Brain Research. 67: 98-106. PMID 10101237 DOI: 10.1016/S0169-328X(99)00047-9  0.383
1999 Bastianetto S, Ramassamy C, Poirier J, Quirion R. Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Research. Molecular Brain Research. 66: 35-41. PMID 10095075 DOI: 10.1016/S0169-328X(99)00002-9  0.32
1999 Abounader R, Elhusseiny A, Cohen Z, Olivier A, Stanimirovic D, Quirion R, Hamel E. Expression of neuropeptide Y receptors mRNA and protein in human brain vessels and cerebromicrovascular cells in culture. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 19: 155-63. PMID 10027771 DOI: 10.1097/00004647-199902000-00007  0.372
1998 Durand M, Coronas V, Jourdan F, Quirion R. Developmental and aging aspects of the cholinergic innervation of the olfactory bulb. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 16: 777-85. PMID 10198824 DOI: 10.1016/S0736-5748(98)00087-2  0.31
1998 Dumont Y, Jacques D, Bouchard P, Quirion R. Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains. The Journal of Comparative Neurology. 402: 372-84. PMID 9853905 DOI: 10.1002/(Sici)1096-9861(19981221)402:3<372::Aid-Cne6>3.0.Co;2-2  0.382
1998 Flores G, Wood GK, Barbeau D, Quirion R, Srivastava LK. Lewis and Fischer rats: a comparison of dopamine transporter and receptors levels. Brain Research. 814: 34-40. PMID 9838033 DOI: 10.1016/S0006-8993(98)01011-7  0.518
1998 Jacques D, Tong Y, Shen SH, Quirion R. Discrete distribution of the neuropeptide Y Y5 receptor gene in the human brain: an in situ hybridization study. Brain Research. Molecular Brain Research. 61: 100-7. PMID 9795164 DOI: 10.1016/S0169-328X(98)00208-3  0.383
1998 Kar S, Issa AM, Seto D, Auld DS, Collier B, Quirion R. Amyloid beta-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices. Journal of Neurochemistry. 70: 2179-87. PMID 9572306 DOI: 10.1046/J.1471-4159.1998.70052179.X  0.565
1998 St-Pierre JA, Dumont Y, Nouel D, Herzog H, Hamel E, Quirion R. Preferential expression of the neuropeptide Y Y1 over the Y2 receptor subtype in cultured hippocampal neurons and cloning of the rat Y2 receptor. British Journal of Pharmacology. 123: 183-94. PMID 9489605 DOI: 10.1038/Sj.Bjp.0701589  0.431
1998 Rowe WB, Spreekmeester E, Meaney MJ, Quirion R, Rochford J. Reactivity to novelty in cognitively-impaired and cognitively-unimpaired aged rats and young rats. Neuroscience. 83: 669-80. PMID 9483551 DOI: 10.1016/S0306-4522(97)00464-8  0.32
1998 Auld DS, Kar S, Quirion R. Beta-amyloid peptides as direct cholinergic neuromodulators: a missing link? Trends in Neurosciences. 21: 43-9. PMID 9464686 DOI: 10.1016/S0166-2236(97)01144-2  0.549
1998 Dumont Y, Fournier A, Quirion R. Expression and Characterization of the Neuropeptide Y Y5Receptor Subtype in the Rat Brain The Journal of Neuroscience. 18: 5565-5574. DOI: 10.1523/Jneurosci.18-15-05565.1998  0.452
1998 Doré S, Kar S, Auld D, Chabot J, Quirion R. Autoradiographic Localization of Growth Factor Receptors in Neuronal Tissues Current Protocols in Pharmacology. 3. DOI: 10.1002/0471141755.Ph0802S03  0.588
1997 Wood GK, Liang JJ, Flores G, Ahmad S, Quirion R, Srivastava LK. Cloning and in situ hybridization analysis of the expression of polysialyltransferase mRNA in the developing and adult rat brain. Brain Research. Molecular Brain Research. 51: 69-81. PMID 9427508 DOI: 10.1016/S0169-328X(97)00209-X  0.514
1997 Bouchard P, Maurice T, St-Pierre S, Privat A, Quirion R. Neuropeptide Y and the calcitonin gene-related peptide attenuate learning impairments induced by MK-801 via a sigma receptor-related mechanism. The European Journal of Neuroscience. 9: 2142-51. PMID 9421174 DOI: 10.1111/J.1460-9568.1997.Tb01381.X  0.37
1997 Kar S, Seto D, Doré S, Hanisch U, Quirion R. Insulin-like growth factors-I and -II differentially regulate endogenous acetylcholine release from the rat hippocampal formation. Proceedings of the National Academy of Sciences of the United States of America. 94: 14054-9. PMID 9391151 DOI: 10.1073/Pnas.94.25.14054  0.32
1997 van Rossum D, Hanisch UK, Quirion R. Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neuroscience and Biobehavioral Reviews. 21: 649-78. PMID 9353797 DOI: 10.1016/S0149-7634(96)00023-1  0.387
1997 Tong Y, Dumont Y, Shen SH, Quirion R. Comparative developmental profile of the neuropeptide Y Y1 receptor gene and protein in the rat brain. Brain Research. Molecular Brain Research. 48: 323-32. PMID 9332730 DOI: 10.1016/S0169-328X(97)00107-1  0.414
1997 Pheng LH, Quirion R, Iyengar S, Fournier A, Regoli D. The rabbit ileum: a sensitive and selective preparation for the neuropeptide Y Y5 receptor. European Journal of Pharmacology. 333: R3-5. PMID 9314048 DOI: 10.1016/S0014-2999(97)01161-8  0.357
1997 Rowe WB, Nicot A, Sharma S, Gully D, Walker CD, Rostène WH, Meaney MJ, Quirion R. Central administration of the neurotensin receptor antagonist, SR48692, modulates diurnal and stress-related hypothalamic-pituitary-adrenal activity. Neuroendocrinology. 66: 75-85. PMID 9263204 DOI: 10.1159/000127223  0.322
1997 Mufson EJ, Lavine N, Jaffar S, Kordower JH, Quirion R, Saragovi HU. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Experimental Neurology. 146: 91-103. PMID 9225742 DOI: 10.1006/Exnr.1997.6504  0.373
1997 Pheng LH, Fournier A, Dumont Y, Quirion R, Regoli D. The dog saphenous vein: a sensitive and selective preparation for the Y2 receptor of neuropeptide Y. European Journal of Pharmacology. 327: 163-7. PMID 9200555 DOI: 10.1016/S0014-2999(97)89656-2  0.337
1997 Nicot A, Rowe WB, De Kloet ER, Betancur C, Jessop DS, Lightman SL, Quirion R, Rostène W, Bérod A. Endogenous neurotensin regulates hypothalamic-pituitary-adrenal axis activity and peptidergic neurons in the rat hypothalamic paraventricular nucleus. Journal of Neuroendocrinology. 9: 263-9. PMID 9147289 DOI: 10.1046/J.1365-2826.1997.00581.X  0.316
1997 Doré S, Kar S, Quirion R. Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. Proceedings of the National Academy of Sciences of the United States of America. 94: 4772-7. PMID 9114067 DOI: 10.1073/Pnas.94.9.4772  0.34
1997 Nouel D, Faure MP, St Pierre JA, Alonso R, Quirion R, Beaudet A. Differential binding profile and internalization process of neurotensin via neuronal and glial receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 1795-803. PMID 9030638 DOI: 10.1523/Jneurosci.17-05-01795.1997  0.423
1997 Kitaichi K, Hersi A, Richard J, Srivastava L, Quirion R. Antisense oligodeoxynucleotide to the muscarinic M2 receptor supports its role as a negative autoreceptor regulating acetylcholine release Life Sciences. 60: 1195. DOI: 10.1016/S0024-3205(97)84363-9  0.318
1996 Trinh T, van Dumont Y, Quirion R. High levels of specific neuropeptide Y/pancreatic polypeptide receptors in the rat hypothalamus and brainstem. European Journal of Pharmacology. 318: R1-3. PMID 9007534 DOI: 10.1016/S0014-2999(96)00863-1  0.371
1996 Chabot JG, Kar S, Quirion R. Autoradiographical and immunohistochemical analysis of receptor localization in the central nervous system. The Histochemical Journal. 28: 729-45. PMID 8968726 DOI: 10.1007/Bf02272147  0.362
1996 Flores G, Wood GK, Liang JJ, Quirion R, Srivastava LK. Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 7366-75. PMID 8929443 DOI: 10.1523/Jneurosci.16-22-07366.1996  0.519
1996 Le Jeune H, Aubert I, Jourdan F, Quirion R. Developmental profiles of various cholinergic markers in the rat main olfactory bulb using quantitative autoradiography. The Journal of Comparative Neurology. 373: 433-50. PMID 8889937 DOI: 10.1002/(Sici)1096-9861(19960923)373:3<433::Aid-Cne8>3.0.Co;2-3  0.627
1996 Le Jeune H, Cécyre D, Rowe W, Meaney MJ, Quirion R. Ionotropic glutamate receptor subtypes in the aged memory-impaired and unimpaired Long-Evans rat. Neuroscience. 74: 349-63. PMID 8865188 DOI: 10.1016/0306-4522(96)00213-8  0.41
1996 Hersi AI, Rowe W, Gaudreau P, Quirion R. Dopamine D1 receptor ligands modulate cognitive performance and hippocampal acetylcholine release in memory-impaired aged rats. Neuroscience. 69: 1067-74. PMID 8848095 DOI: 10.1016/0306-4522(95)00319-E  0.377
1996 Ménard DP, van Rossum D, Kar S, Quirion R. Alteration of calcitonin gene related peptide and its receptor binding sites during the development of tolerance to mu and delta opioids. Canadian Journal of Physiology and Pharmacology. 73: 1089-95. PMID 8846407 DOI: 10.1139/Y95-156  0.323
1996 van Rossum D, Ménard DP, Chang JK, Quirion R. Comparative affinities of human adrenomedullin for 125I-labelled human alpha calcitonin gene related peptide ([125I]hCGRP alpha) and 125I-labelled Bolton-Hunter rat amylin ([125I]BHrAMY) specific binding sites in the rat brain. Canadian Journal of Physiology and Pharmacology. 73: 1084-8. PMID 8846406 DOI: 10.1139/Y95-155  0.353
1996 Jacques D, Tong Y, Dumont Y, Shen SH, Quirion R. Expression of the neuropeptide Y Y1 receptor mRNA in the human brain: an in situ hybridization study. Neuroreport. 7: 1053-6. PMID 8804050 DOI: 10.1097/00001756-199604100-00020  0.373
1996 Dumont Y, Fournier A, St-Pierre S, Quirion R. Autoradiographic distribution of [125I]Leu31,Pro34]PYY and [125I]PYY3-36 binding sites in the rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands. Synapse (New York, N.Y.). 22: 139-58. PMID 8787130 DOI: 10.1002/(Sici)1098-2396(199602)22:2<139::Aid-Syn7>3.0.Co;2-E  0.414
1996 LeSauteur L, Maliartchouk S, Le Jeune H, Quirion R, Saragovi HU. Potent human p140-TrkA agonists derived from an anti-receptor monoclonal antibody. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 1308-16. PMID 8778282 DOI: 10.1523/Jneurosci.16-04-01308.1996  0.321
1996 Tong Y, Dumont Y, Shen SH, Herzog H, Shine J, Quirion R. Expression of the neuropeptide Y Y1 receptor in human embryonic kidney 293 cells: ligand binding characteristics, in situ hybridization and receptor autoradiography. Brain Research. Molecular Brain Research. 34: 303-8. PMID 8750833 DOI: 10.1016/0169-328X(95)00176-S  0.377
1996 Dumont Y, St-Pierre JA, Quirion R. Comparative autoradiographic distribution of neuropeptide Y Y1 receptors visualized with the Y1 receptor agonist [125I][Leu31,Pro34]PYY and the non-peptide antagonist [3H]BIBP3226. Neuroreport. 7: 901-4. PMID 8724669 DOI: 10.1097/00001756-199603220-00013  0.438
1996 Aubert I, Cécyre D, Gauthier S, Quirion R. Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain. The Journal of Comparative Neurology. 369: 31-55. PMID 8723701 DOI: 10.1002/(Sici)1096-9861(19960520)369:1<31::Aid-Cne3>3.0.Co;2-L  0.674
1996 Flores G, Barbeau D, Quirion R, Srivastava LK. Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 2020-6. PMID 8604046 DOI: 10.1523/Jneurosci.16-06-02020.1996  0.546
1996 Menard D, van Rossum D, Kar S, St Pierre S, Sutak M, Jhamandas K, Quirion R. A calcitonin gene-related peptide receptor antagonist prevents the development of tolerance to spinal morphine analgesia The Journal of Neuroscience. 16: 2342-2351. DOI: 10.1523/Jneurosci.16-07-02342.1996  0.306
1995 Poirier J, Delisle MC, Quirion R, Aubert I, Farlow M, Lahiri D, Hui S, Bertrand P, Nalbantoglu J, Gilfix BM, Gauthier S. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 92: 12260-4. PMID 8618881 DOI: 10.1073/Pnas.92.26.12260  0.632
1995 Le Jeune H, Aubert I, Jourdan F, Quirion R. Comparative laminar distribution of various autoradiographic cholinergic markers in adult rat main olfactory bulb. Journal of Chemical Neuroanatomy. 9: 99-112. PMID 8561953 DOI: 10.1016/0891-0618(95)00070-N  0.621
1995 Bouchard P, Monnet F, Bergeron R, Roman F, Junien J‐, de Montigny C, Debonnel G, Quirion R. In Vivo Modulation of Sigma Receptor Sites by Calcitonin Gene‐related Peptide in the Mouse and Rat Hippocampal Formation: Radioligand Binding and Electrophysiological Studies European Journal of Neuroscience. 7: 1952-1962. PMID 8528471 DOI: 10.1111/J.1460-9568.1995.Tb00718.X  0.411
1995 Parent A, Rowe W, Meaney MJ, Quirion R. Increased production of inositol phosphates and diacylglycerol in aged cognitively impaired rats after stimulation of muscarinic, metabotropic-glutamate and endothelin receptors. The Journal of Pharmacology and Experimental Therapeutics. 272: 1110-6. PMID 7891323  0.519
1995 Quirion R, Wilson A, Rowe W, Aubert I, Richard J, Doods H, Parent A, White N, Meaney MJ. Facilitation of acetylcholine release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impaired. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 1455-62. PMID 7869110 DOI: 10.1523/Jneurosci.15-02-01455.1995  0.704
1995 Dumont Y, Cadieux A, Pheng LH, Fournier A, St-Pierre S, Quirion R. Peptide YY derivatives as selective neuropeptide Y/peptide YY Y1 and Y2 agonists devoided of activity for the Y3 receptor sub-type. Brain Research. Molecular Brain Research. 26: 320-4. PMID 7854062 DOI: 10.1016/0169-328X(94)90105-8  0.366
1995 Kar S, Quirion R. Neuropeptide receptors in developing and adult rat spinal cord: An in vitro quantitative autoradiography study of calcitonin gene-related peptide, neurokinins, μ-opioid, galanin, somatostatin, neurotensin and vasoactive intestinal polypeptide receptors Journal of Comparative Neurology. 354: 253-281. PMID 7782502 DOI: 10.1002/Cne.903540208  0.358
1995 Rowe W, Viau V, Meaney MJ, Quirion R. Stimulation of CRH-mediated ACTH secretion by central administration of neurotensin: evidence for the participation of the paraventricular nucleus. Journal of Neuroendocrinology. 7: 109-17. PMID 7767323 DOI: 10.1111/J.1365-2826.1995.Tb00673.X  0.343
1995 Yashpal K, Pitcher GM, Parent A, Quirion R, Coderre TJ. Noxious thermal and chemical stimulation induce increases in 3H-phorbol 12,13-dibutyrate binding in spinal cord dorsal horn as well as persistent pain and hyperalgesia, which is reduced by inhibition of protein kinase C. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 3263-72. PMID 7751909 DOI: 10.1523/Jneurosci.15-05-03263.1995  0.463
1995 Barbeau D, Liang JJ, Robitaille Y, Quirion R, Srivastava LK. Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains Proceedings of the National Academy of Sciences of the United States of America. 92: 2785-2789. PMID 7708724 DOI: 10.1073/Pnas.92.7.2785  0.309
1995 Aubert I, Rowe W, Meaney MJ, Gauthier S, Quirion R. Cholinergic markers in aged cognitively impaired Long-Evans rats. Neuroscience. 67: 277-92. PMID 7675169 DOI: 10.1016/0306-4522(95)00056-O  0.686
1995 Jacques D, Cadieux A, Dumont Y, Quirion R. Apparent affinity and potency of BIBP3226, a non-peptide neuropeptide Y receptor antagonist, on purported neuropeptide Y Y1, Y2 and Y3 receptors European Journal of Pharmacology. 278. PMID 7664808 DOI: 10.1016/0014-2999(95)00179-O  0.397
1995 Krieger C, Jacques D, Parent A, Quirion R. [3H]phorbol 12,13-dibutyrate/PKC binding in thoracic spinal cord: no change in amyotrophic lateral sclerosis. Neuroreport. 6: 1381-4. PMID 7488729 DOI: 10.1097/00001756-199507100-00005  0.484
1995 Hersi A, Richard J, Gaudreau P, Quirion R. Local modulation of hippocampal acetylcholine release by dopamine D1 receptors: a combined receptor autoradiography and in vivo dialysis study The Journal of Neuroscience. 15: 7150-7157. DOI: 10.1523/Jneurosci.15-11-07150.1995  0.353
1995 Quirion R, Aubert I, Wilson A, Rowe W, Dpods H, Meaney M. The age-memory impaired rat: A model to study cholinergic functions in old age and the potential usefulness of M2-cholinergic antagonists to reverse cognitive impairments Life Sciences. 56: 1048. DOI: 10.1016/0024-3205(95)93809-S  0.316
1994 Aubert I, Poirier J, Gauthier S, Quirion R. Multiple cholinergic markers are unexpectedly not altered in the rat dentate gyrus following entorhinal cortex lesions. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 2476-84. PMID 8182423 DOI: 10.1523/Jneurosci.14-05-02476.1994  0.681
1994 Parent A, Quirion R. Differential localization and pH dependency of phosphoinositide 1,4,5-IP3, 1,3,4,5-IP4 and IP6 receptors in rat and human brains. The European Journal of Neuroscience. 6: 67-74. PMID 8130933 DOI: 10.1111/J.1460-9568.1994.Tb00248.X  0.556
1994 Quirion R, Richard J, Wilson A. Muscarinic and nicotinic modulation of cortical acetylcholine release monitored by in vivo microdialysis in freely moving adult rats. Synapse. 17: 92-100. PMID 8091306 DOI: 10.1002/Syn.890170205  0.367
1994 Nicot A, Bérod A, Gully D, Rowe W, Quirion R, de Kloet ER, Rostène W. Blockade of neurotensin binding in the rat hypothalamus and of the central action of neurotensin on the hypothalamic-pituitary-adrenal axis with non-peptide receptor antagonists. Neuroendocrinology. 59: 572-8. PMID 8084381 DOI: 10.1159/000126707  0.405
1994 Kar S, Quirion R, Parent A. An interaction between inositol hexakisphosphate (IP6) and insulin-like growth factor II receptor binding sites in the rat brain. Neuroreport. 5: 625-8. PMID 8025258  0.484
1994 Parent A, Poirier J, Baccichet A, Quirion R. Regulation of 1,4,5-IP3, 1,3,4,5-IP4 and IP6 binding sites following entorhinal cortex lesions in rat brain. Neuroscience. 61: 565-73. PMID 7969930 DOI: 10.1016/0306-4522(94)90434-0  0.554
1994 Morency MA, Quirion R, Mishra RK. Distribution of cholecystokinin receptors in the bovine brain: a quantitative autoradiographic study. Neuroscience. 62: 307-316. PMID 7816208 DOI: 10.1016/0306-4522(94)90334-4  0.397
1994 Zupanc GK, Cécyre D, Maler L, Zupanc MM, Quirion R. The distribution of somatostatin binding sites in the brain of gymnotiform fish, Apteronotus leptorhynchus. Journal of Chemical Neuroanatomy. 7: 49-63. PMID 7802970 DOI: 10.1016/0891-0618(94)90007-8  0.325
1994 Alonso R, Poirier J, O'Donnell D, Buisson N, Diorio J, Boksa P, Quirion R. Statin, a marker of cell cycle arrest, is overexpressed during the early phase of delayed NMDA toxicity in hippocampal cell cultures. Molecular and Cellular Neurosciences. 5: 530-9. PMID 7704426 DOI: 10.1006/Mcne.1994.1065  0.338
1994 Kar S, Quirion R. Galanin receptor binding sites in adult rat spinal cord respond differentially to neonatal capsaicin, dorsal rhizotomy and peripheral axotomy European Journal of Neuroscience. 6: 1917-1921. PMID 7704302 DOI: 10.1111/J.1460-9568.1994.Tb00583.X  0.323
1994 Chaudieu I, St-Pierre JA, Quirion R, Boksa P. GABAA receptor-mediated inhibition of N-methyl-D-aspartate-evoked [3H]dopamine release from mesencephalic cell cultures. European Journal of Pharmacology. 264: 361-9. PMID 7698177 DOI: 10.1016/0014-2999(94)00492-7  0.347
1994 Yashpal K, Kar S, Quirion R, Hui-Chan CW, Henry JL. Noxious stimulation decreases substance P binding in rat spinal dorsal horn: competition by endogenous ligand? Neuroreport. 5: 2101-4. PMID 7532453 DOI: 10.1097/00001756-199410270-00028  0.345
1994 Weld MM, Kar S, Maler L, Quirion R. The distribution of tachykinin binding sites in the brain of an electric fish (Apteronotus leptorhynchus). Journal of Chemical Neuroanatomy. 7: 123-39. PMID 7531453 DOI: 10.1016/0891-0618(94)90024-8  0.341
1994 Kar S, Rees RG, Quirion R. Altered calcitonin gene-related peptide, substance P and enkephalin immunoreactivities and receptor binding sites in the dorsal spinal cord of the polyarthritic rat. The European Journal of Neuroscience. 6: 345-54. PMID 7517279 DOI: 10.1111/J.1460-9568.1994.Tb00277.X  0.38
1993 Parent A, Dea D, Quirion R, Poirier J. [3H]phorbol ester binding sites and neuronal plasticity in the hippocampus following entorhinal cortex lesions. Brain Research. 607: 23-32. PMID 8481798 DOI: 10.1016/0006-8993(93)91485-B  0.545
1993 Dumont Y, Satoh H, Cadieux A, Taoudi-Benchekroun M, Pheng LH, St-Pierre S, Fournier A, Quirion R. Evaluation of truncated neuropeptide Y analogues with modifications of the tyrosine residue in position 1 on Y1, Y2 and Y3 receptor sub-types. European Journal of Pharmacology. 238: 37-45. PMID 8405081 DOI: 10.1016/0014-2999(93)90502-9  0.384
1993 van Rossum D, Ménard DP, Quirion R. Effect of guanine nucleotides and temperature on calcitonin gene-related peptide receptor binding sites in brain and peripheral tissues. Brain Research. 617: 249-57. PMID 8402153 DOI: 10.1016/0006-8993(93)91092-7  0.369
1993 Lal S, Nair NP, Cecyre D, Quirion R. Levomepromazine receptor binding profile in human brain--implications for treatment-resistant schizophrenia. Acta Psychiatrica Scandinavica. 87: 380-3. PMID 8395131 DOI: 10.1111/J.1600-0447.1993.Tb03391.X  0.332
1993 Prasad Sen A, Boksa P, Quirion R. Brain calcium channel related dihydropyridine and phenylalkylamine binding sites in Alzheimer's, Parkinson's and Huntington's diseases Brain Research. 611: 216-221. PMID 8392892 DOI: 10.1016/0006-8993(93)90505-H  0.319
1993 Danik M, Chabot JG, Hassan-Gonzalez D, Suh M, Quirion R. Localization of sulfated glycoprotein-2/clusterin mRNA in the rat brain by in situ hybridization. The Journal of Comparative Neurology. 334: 209-27. PMID 8366194 DOI: 10.1002/Cne.903340205  0.328
1993 Kar S, Baccichet A, Quirion R, Poirier J. Entorhinal cortex lesion induces differential responses in [125I]insulin-like growth factor I, [125I]insulin-like growth factor II and [125I]insulin receptor binding sites in the rat hippocampal formation. Neuroscience. 55: 69-80. PMID 8350993 DOI: 10.1016/0306-4522(93)90455-O  0.339
1993 Kar S, Chabot JG, Quirion R. Quantitative autoradiographic localization of [125I]insulin-like growth factor I, [125I]insulin-like growth factor II, and [125I]insulin receptor binding sites in developing and adult rat brain. The Journal of Comparative Neurology. 333: 375-97. PMID 8349849 DOI: 10.1002/Cne.903330306  0.343
1993 Allaoua H, Chaudieu I, Alonso R, Quirion R, Boksa P. Muscarinic potentiation of excitatory amino acid-evoked dopamine release in mesencephalic cells: Specificity for the NMDA response and role of intracellular messengers Synapse. 15: 39-47. PMID 8310424 DOI: 10.1002/Syn.890150105  0.365
1993 Quirion R, Aubert I, Araujo DM, Hersi A, Gaudreau P. Autoradiographic distribution of putative muscarinic receptor sub-types in mammalian brain. Progress in Brain Research. 98: 85-93. PMID 8248541 DOI: 10.1016/S0079-6123(08)62384-5  0.707
1993 Watling KJ, Guard S, Krause JE, Takeda Y, Quirion R, Zarnegar R, Pain D, Franks R. On the presence of NK2 receptor subtypes in peripheral and central tissues. Regulatory Peptides. 46: 311-3. PMID 8210495 DOI: 10.1016/0167-0115(93)90070-O  0.31
1993 Gouarderes C, Jhamandas K, Cridland R, Cros J, Quirion R, Zajac JM. Opioid and substance p receptor adaptations in the rat spinal cord following sub-chronic intrathecal treatment with morphine and naloxone Neuroscience. 54: 799-807. PMID 7687333 DOI: 10.1016/0306-4522(93)90249-F  0.333
1993 Martel JC, St-Pierre S, Quirion R. Comparative distribution of neuropeptide Y immunoreactivity and receptor autoradiography in rat forebrain. Peptides. 15-20. PMID 2856639 DOI: 10.1016/0196-9781(88)90217-3  0.407
1993 Seto D, Hanisch U, Villemain F, Beaudet A, Quirion R. Anatomical and Functional Approaches to Study of Interleukin 2 and Its Receptors in Brain Methods in Neurosciences. 16: 173-184. DOI: 10.1016/B978-0-12-185281-8.50016-8  0.342
1993 Aubert I, Rowe W, Meaney M, Quirion R. [3H]AF-DX 384/muscarinic-M2 receptor binding sites are increased in certain cortical brain regions of aged memory-impaired as compared to memory-unimpaired rats Life Sciences. 52: 591. DOI: 10.1016/0024-3205(93)90398-M  0.388
1992 Araujo DM, Lapchak PA, Quirion R. Heterogeneous binding of [3H]4-DAMP to muscarinic cholinergic sites in the rat brain: evidence from membrane binding and autoradiographic studies. Synapse (New York, N.Y.). 9: 165-76. PMID 1776129 DOI: 10.1002/Syn.890090303  0.377
1992 Aubert I, Araujo DM, Cécyre D, Robitaille Y, Gauthier S, Quirion R. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. Journal of Neurochemistry. 58: 529-41. PMID 1729398 DOI: 10.1111/J.1471-4159.1992.Tb09752.X  0.642
1992 Yashpal K, Sarrieau A, Quirion R. [125I]vasoactive intestinal polypeptide binding sites: quantitative autoradiographic distribution in the rat spinal cord. Journal of Chemical Neuroanatomy. 4: 439-46. PMID 1664212 DOI: 10.1016/0891-0618(91)90024-7  0.329
1992 Aubert I, Cécyre D, Gauthier S, Quirion R. Characterization and autoradiographic distribution of [3H]AF-DX 384 binding to putative muscarinic M2 receptors in the rat brain. European Journal of Pharmacology. 217: 173-84. PMID 1425938 DOI: 10.1016/0014-2999(92)90843-S  0.671
1992 Liu YF, Quirion R. Modulatory Role of Glutathione on μ‐Opioid, Substance P/Neurokinin‐1, and Kainic Acid Receptor Binding Sites Journal of Neurochemistry. 59: 1024-1032. PMID 1379628 DOI: 10.1111/J.1471-4159.1992.Tb08344.X  0.391
1992 Mongeau R, Welner SA, Quirion R, Suranyi-Cadotte BE. Further evidence for differential affinity states of the serotonin1A receptor in rat hippocampus. Brain Research. 590: 229-38. PMID 1358403 DOI: 10.1016/0006-8993(92)91100-S  0.357
1992 Krantic S, Robitaille Y, Quirion R. Deficits in the somatostatin SS1 receptor sub-type in frontal and temporal cortices in Alzheimer's disease. Brain Research. 573: 299-304. PMID 1354549 DOI: 10.1016/0006-8993(92)90776-6  0.393
1992 Kar S, Quirion R. Quantitative autoradiographic localization of [125I] neuropeptide Y receptor binding sites in rat spinal cord and the effects of neonatal capsaicin, dorsal rhizotomy and peripheral axotomy Brain Research. 574: 333-337. PMID 1322224 DOI: 10.1016/0006-8993(92)90836-X  0.362
1992 Quirion R, Van Rossum D, Dumont Y, St-Pierre S, Fournier A. Characterization of CGRP1 and CGRP2 receptor subtypes. Annals of the New York Academy of Sciences. 657: 88-105. PMID 1322107 DOI: 10.1111/J.1749-6632.1992.Tb22759.X  0.354
1992 Allaoua H, Chaudieu I, Krieger C, Boksa P, Privat A, Quirion R. Alterations in spinal cord excitatory amino acid receptors in amyotrophic lateral sclerosis patients Brain Research. 579: 169-172. PMID 1320444 DOI: 10.1016/0006-8993(92)90758-2  0.34
1992 Mimeault M, Quirion R, Dumont Y, St-Pierre S, Fournier A. Structure-activity study of hCGRP8-37, a calcitonin gene-related peptide receptor antagonist. Journal of Medicinal Chemistry. 35: 2163-8. PMID 1319490 DOI: 10.1021/Jm00090A003  0.363
1992 Dumont Y, Martel JC, Fournier A, St-Pierre S, Quirion R. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Progress in Neurobiology. 38: 125-67. PMID 1312243 DOI: 10.1016/0301-0082(92)90038-G  0.345
1992 Paré M, Descarries L, Quirion R. Up-regulation of 5-hydroxytryptamine2 and neurokinin-1 receptors associated with serotonin/substance P hyperinnervation in the rat inferior olive. Neuroscience. 51: 97-106. PMID 1281526 DOI: 10.1016/0306-4522(92)90474-G  0.624
1992 Yashpal K, Pitcher G, Kar S, Quirion R, Henry J. Substance P and opioid mechanisms in antinociception produced by noxious cutaneous stimulation in the rat — A physiological and receptor binding study Regulatory Peptides. 37: S180. DOI: 10.1016/0167-0115(92)91035-X  0.359
1991 Lapchak PA, Araujo DM, Quirion R, Beaudet A. Chronic estradiol treatment alters central cholinergic function in the female rat: effect on choline acetyltransferase activity, acetylcholine content, and nicotinic autoreceptor function. Brain Research. 525: 249-55. PMID 2253030 DOI: 10.1016/0006-8993(90)90871-8  0.365
1991 Quirion R, Martel JC, Dumont Y, Cadieux A, Jolicoeur F, St-Pierre S, Fournier A. Neuropeptide Y receptors: autoradiographic distribution in the brain and structure-activity relationships. Annals of the New York Academy of Sciences. 611: 58-72. PMID 2174224 DOI: 10.1111/J.1749-6632.1990.Tb48922.X  0.338
1991 Araujo DM, Chabot JG, Quirion R. Potential neurotrophic factors in the mammalian central nervous system: functional significance in the developing and aging brain. International Review of Neurobiology. 32: 141-74. PMID 1981884 DOI: 10.1016/S0074-7742(08)60582-6  0.316
1991 Dumont Y, Fournier A, St-Pierre S, Schwartz TW, Quirion R. Differential distribution of neuropeptide Y1 and Y2 receptors in the rat brain. European Journal of Pharmacology. 191: 501-3. PMID 1964914 DOI: 10.1016/0014-2999(90)94189-5  0.384
1991 Gauthier S, Gauthier L, Bouchard R, Quirion R, Sultan S. Treatment of Alzheimer's disease: Hopes and reality Canadian Journal of Neurological Sciences. 18: 439-441. PMID 1933695 DOI: 10.1017/S0317167100032637  0.409
1991 Lal S, Nair NP, Thavundayil JX, Tawar V, Quirion R, Guyda H. Stereospecificity of the dopamine receptor mediating the growth hormone response to apomorphine in man. Short communication. Journal of Neural Transmission. General Section. 85: 157-64. PMID 1930878 DOI: 10.1007/Bf01244707  0.323
1991 Lapchak PA, Araujo DM, Quirion R, Beaudet A. Neurotensin regulation of endogenous acetylcholine release from rat striatal slices is independent of dopaminergic tone. Journal of Neurochemistry. 56: 651-7. PMID 1899109 DOI: 10.1111/J.1471-4159.1991.Tb08199.X  0.321
1991 Morency MA, Quirion R, Nair NP, Mishra RK. Localization of cholecystokinin binding sites in canine brain using quantitative autoradiography. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 15: 291-6. PMID 1871331 DOI: 10.1016/0278-5846(91)90095-I  0.368
1991 Dennis T, Fournier A, Guard S, St Pierre S, Quirion R. Calcitonin gene-related peptide (hCGRP alpha) binding sites in the nucleus accumbens. Atypical structural requirements and marked phylogenic differences. Brain Research. 539: 59-66. PMID 1849780 DOI: 10.1016/0006-8993(91)90686-P  0.353
1991 Gouardères C, Beaudet A, Zajac JM, Cros J, Quirion R. High resolution radioautographic localization of [125I]FK-33-824-labelled mu opioid receptors in the spinal cord of normal and deafferented rats. Neuroscience. 43: 197-209. PMID 1717884 DOI: 10.1016/0306-4522(91)90427-P  0.333
1991 Yashpal K, Dam TV, Quirion R. Effects of dorsal rhizotomy on neurokinin receptor sub-types in the rat spinal cord: a quantitative autoradiographic study. Brain Research. 552: 240-7. PMID 1717114 DOI: 10.1016/0006-8993(91)90088-D  0.339
1991 Dam TV, Martinelli B, Quirion R. Autoradiographic distribution of brain neurokinin-1/substance P receptors using a highly selective ligand [3H]-[Sar9,Met(O2)11]-substance P. Brain Research. 531: 333-7. PMID 1705154 DOI: 10.1016/0006-8993(90)90796-E  0.372
1991 Krantic S, Martel JC, Quirion R. Brain somatostatin receptors in spontaneously hypertensive rats: an autoradiographic study. Peptides. 12: 81-7. PMID 1675785 DOI: 10.1016/0196-9781(91)90171-K  0.392
1991 Chaudieu I, Mount H, Quirion R, Boksa P. Transient postnatal increases in excitatory amino acid binding sites in rat ventral mesencephalon Neuroscience Letters. 133: 267-270. PMID 1667817 DOI: 10.1016/0304-3940(91)90585-H  0.381
1991 Dam TV, Takeda Y, Krause JE, Quirion R. Comparative autoradiographic distribution of [125I]-neuropeptide gamma and [125I]-neurokinin A binding sites in guinea pig brain. Annals of the New York Academy of Sciences. 632: 377-81. PMID 1659295 DOI: 10.1111/J.1749-6632.1991.Tb33129.X  0.314
1991 Quirion R, Dam T, Guard S. Selective Neurokinin Receptor Radioligandsa Annals of the New York Academy of Sciences. 632: 137-144. PMID 1659292 DOI: 10.1111/J.1749-6632.1991.Tb33102.X  0.335
1991 Liu YF, Quirion R. Presence of Various Carbohydrate Moieties Including β‐Galactose and N‐Acetylglucosamine Residues on Solubilized Porcine Brain Neurokinin‐1/Substance P Receptors Journal of Neurochemistry. 57: 1944-1950. PMID 1658228 DOI: 10.1111/J.1471-4159.1991.Tb06408.X  0.359
1991 Van Rossum D, Dumont Y, Fournier A, St-Pierre S, Quirion R. Effect of dithiothreitol and Gpp(NH)p on [125I]hCGRPα binding sites in brain and peripheral tissues Regulatory Peptides. 34: 95. DOI: 10.1016/0167-0115(91)90406-7  0.304
1991 Dumont Y, Van Rossum D, Dennis T, Fournier A, St-Pierre S, Quirion R. Autoradiographic localization of putative CGRP receptor subtypes in rat brain Regulatory Peptides. 34: 95. DOI: 10.1016/0167-0115(91)90405-6  0.397
1991 Quirion R, Dennis T, Van Rossum D, Mimeault M, Dumont Y, Fournier A, St-Pierre S. Evidence for CGRP receptor sub-types using selective agonists and antagonists Regulatory Peptides. 34: 77. DOI: 10.1016/0167-0115(91)90374-P  0.337
1990 Martial J, Lal S, Dalpé M, Olivier A, de Montigny C, Quirion R. Apparent absence of serotonin1B receptors in biopsied and post-mortem human brain. Synapse (New York, N.Y.). 4: 203-9. PMID 2532791 DOI: 10.1002/Syn.890040305  0.371
1990 Packard MG, Regenold W, Quirion R, White NM. Post-training injection of the acetylcholine M2 receptor antagonist AF-DX 116 improves memory. Brain Research. 524: 72-6. PMID 2400933 DOI: 10.1016/0006-8993(90)90493-U  0.335
1990 Araujo DM, Lapchak PA, Meaney MJ, Collier B, Quirion R. Effects of aging on nicotinic and muscarinic autoreceptor function in the rat brain: relationship to presynaptic cholinergic markers and binding sites. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 10: 3069-78. PMID 2398371 DOI: 10.1523/Jneurosci.10-09-03069.1990  0.399
1990 Danger JM, Tonon MC, Jenks BG, Saint-Pierre S, Martel JC, Fasolo A, Breton B, Quirion R, Pelletier G, Vaudry H. Neuropeptide Y: localization in the central nervous system and neuroendocrine functions. Fundamental & Clinical Pharmacology. 4: 307-40. PMID 2198214 DOI: 10.1111/J.1472-8206.1990.Tb00497.X  0.363
1990 Gaudreau P, Lavigne GJ, Quirion R. Cholecystokinin antagonists proglumide, lorglumide and benzotript, but not L-364,718, interact with brain opioid binding sites. Neuropeptides. 16: 51-5. PMID 2174522 DOI: 10.1016/0143-4179(90)90029-X  0.575
1990 Martel JC, Alagar R, Robitaille Y, Quirion R. Neuropeptide Y receptor binding sites in human brain. Possible alteration in Alzheimer's disease. Brain Research. 519: 228-35. PMID 2168782 DOI: 10.1016/0006-8993(90)90082-M  0.426
1990 Mount H, Quirion R, Kohn‐Alexander J, Boksa P. Subtypes of excitatory amino acid receptors involved in the stimulation of [3H]dopamine release from cell cultures of rat ventral mesencephalon Synapse. 5: 271-280. PMID 2163120 DOI: 10.1002/Syn.890050404  0.318
1990 Lapchak PA, Araujo DM, Quirion R, Beaudet A. Neurotensin regulation of endogenous acetylcholine release from rat cerebral cortex: effect of quinolinic acid lesions of the basal forebrain. Journal of Neurochemistry. 55: 1397-403. PMID 2144584 DOI: 10.1111/J.1471-4159.1990.Tb03152.X  0.308
1990 Sarrieau A, Mitchell JB, Lal S, Olivier A, Quirion R, Meaney MJ. Androgen binding sites in human temporal cortex. Neuroendocrinology. 51: 713-6. PMID 2114007 DOI: 10.1159/000125415  0.353
1990 Quirion R, Aubert I, Robitaille Y, Gauthier S, Araujo DM, Chabot JG. Neurochemical deficits in pathological brain aging: specificity and possible relevance for treatment strategies. Clinical Neuropharmacology. 13: S73-80. PMID 2093419 DOI: 10.1097/00002826-199013003-00008  0.646
1990 Krantic S, Martel JC, Weissmann D, Pujol JF, Quirion R. Quantitative radioautographic study of somatostatin receptors heterogeneity in the rat extrahypothalamic brain. Neuroscience. 39: 127-37. PMID 1982463 DOI: 10.1016/0306-4522(90)90227-U  0.42
1990 Mount H, Boksa P, Chaudieu I, Quirion R. Phencyclidine and related compounds evoked [3H]dopamine release from rat mesencephalic cell cultures by a mechanism independent of the phencyclidine receptor, sigma binding site, or dopamine uptake site Canadian Journal of Physiology and Pharmacology. 68: 1200-1206. PMID 1980428 DOI: 10.1139/Y90-180  0.32
1990 Araujo DM, Lapchak PA, Collier B, Quirion R. Evidence that somatostatin enhances endogenous acetylcholine release in the rat hippocampus. Journal of Neurochemistry. 55: 1546-55. PMID 1976754 DOI: 10.1111/J.1471-4159.1990.Tb04937.X  0.344
1990 Mount H, Quirion R, Chaudieu I, Boksa P. Stimulation of Dopamine Release from Cultured Rat Mesencephalic Cells by Naturally Occurring Excitatory Amino Acids: Involvement of Both N‐Methyl‐D‐Aspartate (NMDA) and Non‐NMDA Receptor Subtypes Journal of Neurochemistry. 55: 268-275. PMID 1972390 DOI: 10.1111/J.1471-4159.1990.Tb08848.X  0.33
1990 Dam TV, Escher E, Quirion R. Visualization of neurokinin-3 receptor sites in rat brain using the highly selective ligand [3H]senktide. Brain Research. 506: 175-9. PMID 1689199 DOI: 10.1016/0006-8993(90)91218-6  0.401
1990 Dam TV, Takeda Y, Krause JE, Escher E, Quirion R. gamma-Preprotachykinin-(72-92)-peptide amide: an endogenous preprotachykinin I gene-derived peptide that preferentially binds to neurokinin-2 receptors. Proceedings of the National Academy of Sciences of the United States of America. 87: 246-50. PMID 1688655 DOI: 10.1073/Pnas.87.1.246  0.365
1989 Lapchak PA, Araujo DM, Quirion R, Collier B. Effect of chronic nicotine treatment on nicotinic autoreceptor function and N-[3H]methylcarbamylcholine binding sites in the rat brain. Journal of Neurochemistry. 52: 483-91. PMID 2911027 DOI: 10.1111/J.1471-4159.1989.Tb09146.X  0.348
1989 Quirion R, Araujo D, Nair NP, Chabot JG. Visualization of growth factor receptor sites in rat forebrain. Synapse (New York, N.Y.). 2: 212-8. PMID 2850628 DOI: 10.1002/Syn.890020307  0.369
1989 Lapchak PA, Araujo DM, Quirion R, Collier B. Presynaptic cholinergic mechanisms in the rat cerebellum: evidence for nicotinic, but not muscarinic autoreceptors. Journal of Neurochemistry. 53: 1843-51. PMID 2809595 DOI: 10.1111/J.1471-4159.1989.Tb09251.X  0.357
1989 Lapchak PA, Araujo DM, Quirion R, Collier B. Binding sites for [3H]AF-DX 116 and effect of AF-DX 116 on endogenous acetylcholine release from rat brain slices. Brain Research. 496: 285-94. PMID 2804636 DOI: 10.1016/0006-8993(89)91075-5  0.396
1989 Regenold W, Araujo DM, Quirion R. Quantitative autoradiographic distribution of [3H]AF-DX 116 muscarinic-M2 receptor binding sites in rat brain. Synapse (New York, N.Y.). 4: 115-25. PMID 2781464 DOI: 10.1002/Syn.890040205  0.386
1989 Araujo DM, Lapchak PA, Regenold W, Quirion R. Characterization of [3H]AF-DX 116 binding sites in the rat brain: evidence for heterogeneity of muscarinic-M2 receptor sites. Synapse (New York, N.Y.). 4: 106-14. PMID 2781463 DOI: 10.1002/Syn.890040204  0.359
1989 Quirion R, Araujo D, Regenold W, Boksa P. Characterization and quantitative autoradiographic distribution of [3H]acetylcholine muscarinic receptors in mammalian brain. Apparent labelling of an M2-like receptor sub-type Neuroscience. 29: 271-289. PMID 2725859 DOI: 10.1016/0306-4522(89)90057-2  0.416
1989 Quirion R, Aubert I, Lapchak PA, Schaum RP, Teolis S, Gauthier S, Araujo DM. Muscarinic receptor subtypes in human neurodegenerative disorders: focus on Alzheimer's disease. Trends in Pharmacological Sciences. 80-4. PMID 2694529  0.646
1989 Araujo DM, Lapchak PA, Collier B, Quirion R. N-[3H]methylcarbamylcholine binding sites in the rat and human brain: relationship to functional nicotinic autoreceptors and alterations in Alzheimer's disease. Progress in Brain Research. 79: 345-52. PMID 2685905 DOI: 10.1016/S0079-6123(08)62494-2  0.37
1989 Boksa P, Quik M, Mitchell JB, Collier B, O'Neil W, Quirion R. Pharmacological activity of N-methyl-carbamylcholine, a novel acetylcholine receptor agonist with selectivity for nicotinic receptors. European Journal of Pharmacology. 173: 93-108. PMID 2606158 DOI: 10.1016/0014-2999(89)90012-5  0.325
1989 Krantic S, Martel JC, Weissmann D, Quirion R. Radioautographic analysis of somatostatin receptor sub-type in rat hypothalamus. Brain Research. 498: 267-78. PMID 2571396 DOI: 10.1016/0006-8993(89)91105-0  0.387
1989 Quirion R. Receptor sites for atrial natriuretic factors in brain and associated structures: an overview. Cellular and Molecular Neurobiology. 9: 45-55. PMID 2540911 DOI: 10.1007/Bf00711442  0.361
1989 Araujo DM, Lapchak PA, Collier B, Chabot JG, Quirion R. Insulin-like growth factor-1 (somatomedin-C) receptors in the rat brain: distribution and interaction with the hippocampal cholinergic system. Brain Research. 484: 130-8. PMID 2540883 DOI: 10.1016/0006-8993(89)90355-7  0.393
1989 Bodnoff SR, Suranyi-Cadotte BE, Quirion R, Meaney MJ. Role of the central benzodiazepine receptor system in behavioral habituation to novelty. Behavioral Neuroscience. 103: 209-12. PMID 2538132 DOI: 10.1037/0735-7044.103.1.209  0.348
1989 Reiner A, Brauth SE, Kitt CA, Quirion R. Distribution of mu, delta, and kappa opiate receptor types in the forebrain and midbrain of pigeons. The Journal of Comparative Neurology. 280: 359-82. PMID 2537344 DOI: 10.1002/Cne.902800304  0.404
1988 Regenold W, Araujo D, Quirion R. Direct visualization of brain M2 muscarinic receptors using the selective antagonist [3H]AF-DX116. European Journal of Pharmacology. 144: 417-9. PMID 3440483 DOI: 10.1016/0014-2999(87)90400-6  0.347
1988 Araujo DM, Lapchak PA, Collier B, Quirion R. Characterization of N-[3H]methylcarbamylcholine binding sites and effect of N-methylcarbamylcholine on acetylcholine release in rat brain. Journal of Neurochemistry. 51: 292-9. PMID 3379410 DOI: 10.1111/J.1471-4159.1988.Tb04869.X  0.412
1988 Araujo DM, Lapchak PA, Robitaille Y, Gauthier S, Quirion R. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. Journal of Neurochemistry. 50: 1914-23. PMID 3373218 DOI: 10.1111/J.1471-4159.1988.Tb02497.X  0.515
1988 Sarrieau A, Dussaillant M, Sapolsky RM, Aitken DH, Olivier A, Lal S, Rostène WH, Quirion R, Meaney MJ. Glucocorticoid binding sites in human temporal cortex. Brain Research. 442: 157-60. PMID 3359250 DOI: 10.1016/0006-8993(88)91444-8  0.339
1988 Leblanc R, Gauthier S, Gauvin M, Quirion R, Palmour R, Masson H. Neurobehavioral effects of intrathecal somatostatinergic treatment in subhuman primates. Neurology. 38: 1887-90. PMID 2904131 DOI: 10.1212/Wnl.38.12.1887  0.354
1988 Quirion R, Dalpé M, DeLéan A. Characterization, distribution and plasticity of atrial natriuretic factor binding sites in brain. Canadian Journal of Physiology and Pharmacology. 66: 280-7. PMID 2838144 DOI: 10.1139/Y88-048  0.402
1988 Quirion R, Pilapil C, Magnan J. Localization of kappa opioid receptor binding sites in human forebrain using [3H]U69,593: comparison with [3H]bremazocine. Cellular and Molecular Neurobiology. 7: 303-7. PMID 2830975 DOI: 10.1007/Bf00711306  0.352
1988 Martel JC, St-Pierre S, Bédard PJ, Quirion R. Comparison of [125I]Bolton-Hunter neuropeptide Y binding sites in the forebrain of various mammalian species. Brain Research. 419: 403-7. PMID 2823968 DOI: 10.1016/0006-8993(87)90617-2  0.337
1988 Dam TV, Escher E, Quirion R. Evidence for the existence of three classes of neurokinin receptors in brain. Differential ontogeny of neurokinin-1, neurokinin-2 and neurokinin-3 binding sites in rat cerebral cortex. Brain Research. 453: 372-6. PMID 2456834 DOI: 10.1016/0006-8993(88)90181-3  0.402
1988 Dam TV, Escher E, Quirion R. Apparent molecular weight of substance P/neurokinin-1 receptors determined using a photoaffinity labelled probe, [(3'-125I) D-Tyro, (4'-N3)Phe8, Nle11]-substance P. Biochemical and Biophysical Research Communications. 149: 297-303. PMID 2446621 DOI: 10.1016/0006-291X(87)91638-X  0.322
1988 Quirion R, Dam TV. Multiple neurokinin receptors: Recent developments Regulatory Peptides. 22: 18-25. DOI: 10.1016/0167-0115(88)90245-5  0.338
1987 Charlton CG, Quirion R, Handelmann GE, Miller RL, Jensen RT, Finkel MS, O'Donohue TL. Secretin receptors in the rat kidney: adenylate cyclase activation and renal effects. Peptides. 7: 865-71. PMID 3797344 DOI: 10.1016/0196-9781(86)90107-5  0.351
1987 Gaudreau P, St-Pierre S, Pert CB, Quirion R. Structure-activity studies of C- and N-terminal fragments of cholecystokinin 26-33 in guinea pig isolated tissues. Neuropeptides. 10: 9-18. PMID 3670570 DOI: 10.1016/0143-4179(87)90084-9  0.658
1987 Boksa P, Quirion R. [3H]N-methyl-carbamylcholine, a new radioligand specific for nicotinic acetylcholine receptors in brain European Journal of Pharmacology. 139: 323-333. PMID 3666008 DOI: 10.1016/0014-2999(87)90590-5  0.357
1987 Gaudreau P, Quirion R, St-Pierre S, Chiueh CC, Pert A. Localization of cholecystokinin receptors in relation to the nigrostriatal and mesolimbic dopaminergic pathways. Neuropeptides. 9: 283-93. PMID 3614556 DOI: 10.1016/0143-4179(87)90003-5  0.578
1987 Quirion R. Characterization and autoradiographic distribution of hemicholinium-3 high-affinity choline uptake sites in mammalian brain. Synapse. 1: 293-303. PMID 3138770 DOI: 10.1002/Syn.890010403  0.386
1987 Contreras PC, Quirion R, Gehlert DR, Contreras ML, O'Donohue TL. Autoradiographic distribution of non-dopaminergic binding sites labeled by [3H]haloperidol in rat brain. Neuroscience Letters. 75: 133-40. PMID 3033560 DOI: 10.1016/0304-3940(87)90286-2  0.344
1987 Suranyi-Cadotte B, Lal S, Nair NP, Lafaille F, Quirion R. Coexistence of central and peripheral benzodiazepine binding sites in the human pineal gland. Life Sciences. 40: 1537-43. PMID 3031403 DOI: 10.1016/0024-3205(87)90387-0  0.329
1987 Metcalf RH, Boegman RJ, Quirion R, Riopelle RJ, Ludwin SK. Effect of quinolinic acid in the nucleus basalis magnocellularis on cortical high-affinity choline uptake. Journal of Neurochemistry. 49: 639-44. PMID 2955081 DOI: 10.1111/J.1471-4159.1987.Tb02911.X  0.354
1987 Quirion R, Robitaille Y, Martial J, Chabot JG, Lemoine P, Pilapil C, Dalpé M. Human brain receptor autoradiography using whole hemisphere sections: a general method that minimizes tissue artefacts. Synapse (New York, N.Y.). 1: 446-54. PMID 2850625 DOI: 10.1002/Syn.890010508  0.359
1987 Quirion R, Welner S, Gauthier S, Bédard P. Neurotensin receptor binding sites in monkey and human brain: autoradiographic distribution and effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment. Synapse. 1: 559-566. PMID 2843996 DOI: 10.1002/Syn.890010608  0.517
1987 Bodnoff SR, Suranyi-Cadotte B, Quirion R, Meaney MJ. Postnatal handling reduces novelty-induced fear and increases [3H]flunitrazepam binding in rat brain. European Journal of Pharmacology. 144: 105-7. PMID 2830116 DOI: 10.1016/0014-2999(87)90016-1  0.378
1987 Pilapil C, Welner S, Magnan J, Gauthier S, Quirion R. Autoradiographic distribution of multiple classes of opioid receptor binding sites in human forebrain Brain Research Bulletin. 19: 611-615. PMID 2825931 DOI: 10.1016/0361-9230(87)90080-3  0.502
1987 Jenck F, Quirion R, Wise RA. Opioid receptor subtypes associated with ventral tegmental facilitation and periaqueductal gray inhibition of feeding. Brain Research. 423: 39-44. PMID 2823993 DOI: 10.1016/0006-8993(87)90822-5  0.315
1987 Dam TV, Quirion R. Pharmacological characterization and autoradiographic localization of substance P receptors in guinea pig brain. Peptides. 7: 855-64. PMID 2432587 DOI: 10.1016/0196-9781(86)90106-3  0.382
1987 Quirion R, Chicheportiche R, Contreras PC, Johnson KM, Lodge D, William Tam S, Woods JH, Zukin SR. Classification and nomenclature of phencyclidine and sigma receptor sites Trends in Neurosciences. 10: 444-446. DOI: 10.1016/0166-2236(87)90094-4  0.341
1986 Quirion R, Boksa P. Autoradiographic distribution of muscarinic [3H]Acetylcholine receptors in rat brain: Comparison with antagonists European Journal of Pharmacology. 123: 170-172. PMID 3754816 DOI: 10.1016/0014-2999(86)90702-8  0.413
1986 Brauth SE, Kitt CA, Reiner A, Quirion R. Neurotensin binding sites in the forebrain and midbrain of the pigeon. The Journal of Comparative Neurology. 253: 358-73. PMID 3025271 DOI: 10.1002/Cne.902530306  0.355
1986 Moyse E, Pasquini F, Quirion R, Beaudet A. 125I-FK 33-824: a selective probe for radioautographic labeling of mu opioid receptors in the brain. Peptides. 7: 351-5. PMID 3016685 DOI: 10.1016/0196-9781(86)90235-4  0.356
1986 Contreras PC, Quirion R, O'Donohue TL. Autoradiographic distribution of phencyclidine receptors in the rat brain using [3H]1-(1-(2-thienyl)cyclohexyl)piperidine ([3H]TCP). Neuroscience Letters. 67: 101-6. PMID 3014394 DOI: 10.1016/0304-3940(86)90380-0  0.422
1986 Martel JC, St-Pierre S, Quirion R. Neuropeptide Y receptors in rat brain: autoradiographic localization. Peptides. 7: 55-60. PMID 3012490 DOI: 10.1016/0196-9781(86)90061-6  0.445
1986 Gouardères C, Kopp N, Cros J, Quirion R. Kappa opioid receptors in human lumbo-sacral spinal cord. Brain Research Bulletin. 16: 355-61. PMID 3011219 DOI: 10.1016/0361-9230(86)90056-0  0.325
1986 Suranyi-Cadotte BE, Dam TV, Bodnoff S, Quirion R. Variability of chronic antidepressant treatments on beta-adrenergic receptor sites. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 9: 765-8. PMID 3003808 DOI: 10.1016/0278-5846(85)90057-0  0.328
1986 Quirion R, Dalpe M, Dam T. Characterization and distribution of receptors for the atrial natriuretic peptides in mammalian brain. Proceedings of the National Academy of Sciences of the United States of America. 83: 174-178. PMID 3001722 DOI: 10.1073/Pnas.83.1.174  0.383
1986 Quirion R, Gaudreau P. Strategies in neuropeptide receptor binding research. Neuroscience and Biobehavioral Reviews. 9: 413-20. PMID 2999656 DOI: 10.1016/0149-7634(85)90019-3  0.569
1986 Quirion R. Characterization of binding sites for two classes of calcium channel antagonists in human forebrain. European Journal of Pharmacology. 117: 139-42. PMID 2935407 DOI: 10.1016/0014-2999(85)90484-4  0.329
1986 Quirion R, Martel JC, Robitaille Y, Etienne P, Wood P, Nair NP, Gauthier S. Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 13: 503-10. PMID 2878714 DOI: 10.1017/S0317167100037215  0.532
1986 Gauthier S, Leblanc R, Robitaille Y, Quirion R, Carlsson G, Beaulieu M, Bouchard R, Dastoor D, Ervin F, Gauthier L. Transmitter-replacement therapy in Alzheimer's disease using intracerebroventricular infusions of receptor agonists. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 13: 394-402. PMID 2878712 DOI: 10.1017/S0317167100036969  0.473
1986 QUIRION R, ETIENNE P, NAIR NPV, PELLETIER G, GAUDREAU P. Neuropeptide Receptors in Human Forebrain: An Autoradiographic Study Annals of the New York Academy of Sciences. 463: 128-131. DOI: 10.1111/J.1749-6632.1986.Tb21521.X  0.571
1985 Quirion R, Dalpé M, De Lean A, Gutkowska J, Cantin M, Genest J. Atrial natriuretic factor (ANF) binding sites in brain and related structures. Peptides. 5: 1167-72. PMID 6241671 DOI: 10.1016/0196-9781(84)90183-9  0.359
1985 Suranyi-Cadotte BE, Dam TV, Quirion R. Antidepressant--anxiolytic interaction: decreased density of benzodiazepine receptors in rat brain following chronic administration of antidepressants. European Journal of Pharmacology. 106: 673-5. PMID 6097466 DOI: 10.1016/0014-2999(84)90079-7  0.379
1985 Pilapil C, Contreras P, O'Donohue TL, Quirion R. Autoradiographic distribution of [3H]dexoxadrol (a phencyclidine-related ligand) binding sites in rat and human brain. Neuroscience Letters. 56: 1-6. PMID 4011043 DOI: 10.1016/0304-3940(85)90431-8  0.36
1985 Quirion R, Richard J, Dam TV. Evidence for the existence of serotonin type-2 receptors on cholinergic terminals in rat cortex. Brain Research. 333: 345-349. PMID 3995301 DOI: 10.1016/0006-8993(85)91590-2  0.415
1985 Quirion R. Comparative localization of putative pre- and postsynaptic markers of muscarinic cholinergic nerve terminals in rat brain. European Journal of Pharmacology. 111: 287-9. PMID 3839459 DOI: 10.1016/0014-2999(85)90771-X  0.325
1985 Quirion R, Lal S, Nair NP, Stratford JG, Ford RM, Olivier A. Comparative autoradiographic distribution of calcium channel antagonist binding sites for 1,4-dihydropyridine and phenylalkylamine in rat, guinea pig and human brain. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 9: 643-9. PMID 3003805 DOI: 10.1016/0278-5846(85)90033-8  0.373
1985 French ED, Pilapil C, Quirion R. Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system European Journal of Pharmacology. 116: 1-9. PMID 2996909 DOI: 10.1016/0014-2999(85)90178-5  0.355
1985 Gouardères C, Cros J, Quirion R. Autoradiographic localization of mu, delta and kappa opioid receptor binding sites in rat and guinea pig spinal cord. Neuropeptides. 6: 331-42. PMID 2995864 DOI: 10.1016/0143-4179(85)90006-X  0.305
1985 Gaudreau P, St-Pierre S, Pert CB, Quirion R. Cholecystokinin receptors in mammalian brain. A comparative characterization and visualization. Annals of the New York Academy of Sciences. 448: 198-219. PMID 2992345 DOI: 10.1111/J.1749-6632.1985.Tb29919.X  0.669
1985 Quirion R, Chiueh CC, Everist HD, Pert A. Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals. Brain Research. 327: 385-9. PMID 2985182 DOI: 10.1016/0006-8993(85)91542-2  0.394
1985 Quirion R, Gaudreau P, Martel JC, St-Pierre S, Zamir N. Possible interactions between dynorphin and dopaminergic systems in rat basal ganglia and substantia nigra. Brain Research. 331: 358-62. PMID 2859094 DOI: 10.1016/0006-8993(85)91563-X  0.54
1985 Wolf SS, Moody TW, Quirion R, O'Donohue TL. Biochemical characterization and autoradiographic localization of central substance P receptors using [125I]physalaemin Brain Research. 332: 299-307. PMID 2581653 DOI: 10.1016/0006-8993(85)90598-0  0.393
1985 Quirion R, Dam TV. Multiple tachykinin receptors in guinea pig brain. High densities of substance K (neurokinin A) binding sites in the substantia nigra. Neuropeptides. 6: 191-204. PMID 2410809 DOI: 10.1016/0143-4179(85)90090-3  0.342
1985 Quirion R, Lafaille F, Nair NP. Comparative potencies of calcium channel antagonists and antischizophrenic drugs on central and peripheral calcium channel binding sites. The Journal of Pharmacy and Pharmacology. 37: 437-40. PMID 2410588 DOI: 10.1111/J.2042-7158.1985.Tb03033.X  0.32
1985 QUIRION R, CSONKA C, ETIENNE P, NAIR NPV, ROBITAILLE Y, GAUDREAU P. Autoradiographic Localization of Cholecystokinin Receptors in Human Brain Annals of the New York Academy of Sciences. 448: 624-626. DOI: 10.1111/J.1749-6632.1985.Tb29969.X  0.568
1984 Quirion R, Pilapil C. Opioid receptor binding profile of [3H]dynorphin A-(1-8) in rat and guinea pig brain. European Journal of Pharmacology. 99: 361-3. PMID 6329791 DOI: 10.1016/0014-2999(84)90148-1  0.4
1984 Mendelsohn FAO, Quirion R, Saavedra JM, Aguilera G, Catt KJ. Autoradiographic localization of angiotensin II receptors in rat brain Proceedings of the National Academy of Sciences of the United States of America. 81: 1575-1579. PMID 6324205 DOI: 10.1073/Pnas.81.5.1575  0.403
1984 Quirion R. Interactions between neurotensin and dopamine in the brain: an overview. Peptides. 4: 609-15. PMID 6318198 DOI: 10.1016/0196-9781(83)90005-0  0.354
1984 Park CH, Massari VJ, Quirion R, Tizabi Y, Shults CW, O'Donohue TL. Characteristics of 3H-substance P binding sites in rat brain membranes. Peptides. 5: 833-6. PMID 6208537 DOI: 10.1016/0196-9781(84)90031-7  0.337
1984 Quirion R, Pilapil C. Comparative potencies of substance P, substance K and neuromedin K on brain substance P receptors. Neuropeptides. 4: 325-9. PMID 6206436 DOI: 10.1016/0143-4179(84)90007-6  0.326
1984 Quirion R, DiMaggio DA, French ED, Contreras PC, Shiloach J, Pert CB, Everist H, Pert A, O'Donohue TL. Evidence for an endogenous peptide ligand for the phencyclidine receptor. Peptides. 5: 967-73. PMID 6095223 DOI: 10.1016/0196-9781(84)90124-4  0.555
1984 Finkel MS, Quirion R, Pert C, Patterson RE. Characterization and autoradiographic distribution of the beta-adrenergic receptor in the rat lung. Pharmacology. 29: 247-54. PMID 6093158 DOI: 10.1159/000138020  0.553
1984 Shults CW, Quirion R, Chronwall B, Chase TN, O'Donohue TL. A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous system. Peptides. 5: 1097-128. PMID 6085163 DOI: 10.1016/0196-9781(84)90177-3  0.354
1984 RICE KC, KONICKI PE, QUIRION R, BURKE TRJ, PERT CB. ChemInform Abstract: SYNTHESIS AND PHARMACOLOGICAL CHARACTERIZATION OF (.+-.)-5,9α-DIMETHYL-2-(2-(4-FLUOROPHENYL)ETHYL)-2′-HYDROXY-6,7-BENZOMORP# HAN (FLUOROPHEN), A LIGAND SUITABLE FOR VISUALIZATION OF OPIATE RECEPTORS IN VIVO Chemischer Informationsdienst. 15. DOI: 10.1002/Chin.198415347  0.525
1983 Quirion R. Autoradiographic localization of a calcium channel antagonist, [3H]nitrendipine, binding site in rat brain. Neuroscience Letters. 36: 267-71. PMID 6866333 DOI: 10.1016/0304-3940(83)90011-3  0.366
1983 Quirion R, Pert CB. Properties of the phencyclidine (PCP) receptors. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 7: 451-6. PMID 6320296 DOI: 10.1016/0278-5846(83)90010-6  0.618
1983 Quirion R, Finkel MS, Mendelsohn FAO, Zamir N. Localization of opiate binding sites in kidney and adrenal gland of the rat. Life Sciences. 33: 299-302. PMID 6319881 DOI: 10.1016/0024-3205(83)90502-7  0.338
1983 Quirion R, Zajac JM, Morgat JL, Roques BP. Autoradiographic distribution of mu and delta opiate receptors in rat brain using highly selective ligands Life Sciences. 33: 227-230. PMID 6319867 DOI: 10.1016/0024-3205(83)90484-8  0.389
1983 Gaudreau P, Quirion R, St-Pierre S, Pert CB. Characterization and visualization of cholecystokinin receptors in rat brain using [3H]pentagastrin. Peptides. 4: 755-62. PMID 6318206 DOI: 10.1016/0196-9781(83)90032-3  0.715
1983 Mendelsohn FAO, Aguilera G, Saavedra JM, Quirion R, Catt KJ. Characteristics and regulation of angiotensin II receptors in pituitary, circumventricular organs and kidney. Clinical and Experimental Hypertension. 5: 1081-1097. PMID 6315266 DOI: 10.3109/10641968309048843  0.358
1983 Rice KC, Konicki PE, Quirion R, Burke TR, Pert CB. Synthesis and pharmacological characterization of (+/-)-5,9 alpha-dimethyl-2-[2-(4-fluorophenyl)ethyl]-2'-hydroxy-6,7-benzomorphan (fluorophen), a ligand suitable for visualization of opiate receptors in vivo. Journal of Medicinal Chemistry. 26: 1643-5. PMID 6313921  0.502
1983 Wolf SS, Moody TW, Quirion R, Shults CW, Chase TN, O'Donohue TL. Autoradiographic visualization of substance P receptors in rat brain European Journal of Pharmacology. 91: 157-158. PMID 6311571 DOI: 10.1016/0014-2999(83)90066-3  0.366
1983 Quirion R, Pert CB. Modulation of phencyclidine receptor sensitivity. Nida Research Monograph. 43: 217-23. PMID 6308454  0.498
1983 Gaudreau P, Quirion R, St-Pierre S, Pert CB. Tritium-sensitive film autoradiography of [3H]cholecystokinin-5/pentagastrin receptors in rat brain. European Journal of Pharmacology. 87: 173-4. PMID 6301853 DOI: 10.1016/0014-2999(83)90071-7  0.685
1983 Altura BT, Quirion R, Pert CB, Altura BM. Phencyclidine ("angel dust") analogs and sigma opiate benzomorphans cause cerebral arterial spasm. Proceedings of the National Academy of Sciences of the United States of America. 80: 865-9. PMID 6298779 DOI: 10.1073/Pnas.80.3.865  0.514
1983 Quirion R, Gaudreau P, St-Pierre S, Rioux F. Localization of neurotensin binding sites in rat kidney. Peptides. 3: 765-9. PMID 6294632 DOI: 10.1016/0196-9781(82)90012-2  0.577
1983 Quirion R, Shults CW, Moody TW, Pert CB, Chase TN, O'Donohue TL. Autoradiographic distribution of substance P receptors in rat central nervous system. Nature. 303: 714-6. PMID 6190094 DOI: 10.1038/303714A0  0.591
1983 Quirion R, Weiss AS, Pert CB. Comparative pharmacological properties and autoradiographic distribution of [3H]ethylketocyclazocine binding sites in rat and guinea pig brain. Life Sciences. 33: 183-6. PMID 6141485 DOI: 10.1016/0024-3205(83)90473-3  0.609
1983 Pert CB, Quirion R. The phencyclidine receptor Trends in Pharmacological Sciences. 4: 12-13. DOI: 10.1016/0165-6147(83)90265-1  0.567
1982 Quirion R, Pert CB. Certain calcium antagonists are potent displacers of [3H]phencyclidine (PCP) binding in rat brain. European Journal of Pharmacology. 83: 155-6. PMID 7128698 DOI: 10.1016/0014-2999(82)90305-3  0.572
1982 Quirion R, Bowen WD, Herkenham M, Pert CB. Visualization and solubilization of rat brain opiate receptors with a "kappa" ligand selectivity pattern. Cellular and Molecular Neurobiology. 2: 333-46. PMID 6305502 DOI: 10.1007/Bf00710853  0.686
1982 Shults CW, Quirion R, Jensen RT, Moody TW, O'Donohue TL, Chase TN. Autoradiographic localization of substance P receptors using 125I substance P Peptides. 3: 1073-1075. PMID 6300806 DOI: 10.1016/0196-9781(82)90076-6  0.329
1982 Olgiati V, Quirion R, Bowen WD, Pert CB. Characterization of type 2 opiate receptors. Life Sciences. 31: 1675-8. PMID 6296570 DOI: 10.1016/0024-3205(82)90183-7  0.681
1982 Quirion R, Bayorh MA, Zerbe RL, Pert CB. Chronic phencyclidine treatment decreases phencyclidine and dopamine receptors in rat brain. Pharmacology, Biochemistry, and Behavior. 17: 699-702. PMID 6294678 DOI: 10.1016/0091-3057(82)90349-5  0.594
1982 Quirion R, Gaudreau P, St-Pierre S, Rioux F, Pert CB. Autoradiographic distribution of [3H]neurotensin receptors in rat brain: visualization by tritium-sensitive film. Peptides. 3: 757-63. PMID 6294631 DOI: 10.1016/0196-9781(82)90011-0  0.707
1982 Quirion R, Hammer RP, Herkenham M, Pert CB. Autoradiographic localization of the phencyclidine/sigma "opiate" receptor in rat brain. Nida Research Monograph. 41: 178-83. PMID 6289117  0.547
1982 Quirion R, Kiso Y, Pert CB. Syndyphalin SD-25: a highly selective ligand for mu opiate receptors. Febs Letters. 141: 203-6. PMID 6284554 DOI: 10.1016/0014-5793(82)80047-1  0.496
1982 Hammer RP, Herkenham M, Pert CB, Quirion R. Correlation of regional brain metabolism with receptor localization during ketamine anesthesia: combined autoradiographic 2-[3H]deoxy-D-glucose receptor binding technique. Proceedings of the National Academy of Sciences of the United States of America. 79: 3067-70. PMID 6283555 DOI: 10.1073/Pnas.79.9.3067  0.579
1982 Quirion R, Pert CB. Amantadine modulates phencyclidine binding site sensitivity in rat brain. Experientia. 38: 955-6. PMID 6215256 DOI: 10.1007/Bf01953674  0.625
1982 Quirion R, Larsen TA, Calne D, Chase T, Rioux F, St-Pierre S, Evarist H, Pert A, Pert CB. ANALYSIS OF [3H]NEUROTENSIN RECEPTORS BY COMPUTERIZED DENSITOMETRY: VISUALIZATION OF CENTRAL AND PERIPHERAL NEUROTENSIN RECEPTORS Annals of the New York Academy of Sciences. 400: 415-417. DOI: 10.1111/J.1749-6632.1982.Tb31599.X  0.566
1982 Quirion R, Kiso Y, Pert CB. Syndyphalin SD-25: A highly selective ligand for μ opiate receptors (1982) FEBS Letters 141,203-206 Febs Letters. 148: 171.  0.493
1981 Quirion R, Rice KC, Skolnick P, Paul S, Pert CB. Stereospecific displacement of [3H]phencyclidine (PCP) receptor binding by an enantiomeric pair of PCP analogs. European Journal of Pharmacology. 74: 107-8. PMID 6459238 DOI: 10.1016/0014-2999(81)90330-7  0.577
1981 Quirion R, Hammer RP, Herkenham M, Pert CB. Phencyclidine (angel dust)/sigma "opiate" receptor: visualization by tritium-sensitive film. Proceedings of the National Academy of Sciences of the United States of America. 78: 5881-5. PMID 6272322 DOI: 10.1073/Pnas.78.9.5881  0.575
1981 Quirion R, Pert CB. Dynorphins: similar relative potencies on mu, delta- and kappa-opiate receptors. European Journal of Pharmacology. 76: 467-8. PMID 6120085 DOI: 10.1016/0014-2999(81)90125-4  0.561
1978 Quirion R, Rioux F, Regoli D. Chronotropic and inotropic effects of neurotensin on spontaneously beating auricles. Canadian Journal of Physiology and Pharmacology. 56: 671-3. PMID 688093 DOI: 10.1139/Y78-108  0.309
Show low-probability matches.